GABRIELLA D'ETTORRE

La piattaforma che sarà utilizzata per le lezioni è MEET.

Le date delle lezioni on line saranno comunicate a mezzo email.

 

 

Per partecipare alle lezioni on line del Corso "PROMOZIONE DELLA SALUTE E SICUREZZA" (1036395)

il link da utilizzare per il collegamento a MEET è il seguente:

 

meet.google.com/gve-ojhm-beb

Part I – General Information

Full Name Gabriella d’Ettorre
Date of Birth 09/05/1968
Place of Birth Lecce (LE)
Citizenship Italian
E-mail gabriella.dettorre@uniroma1.it
Spoken Languages Italian, english

Part II – Education

Type Year Institution Notes
University graduation 1995 Sapienza, University of Rome Master Degree in Medicine and Surgery. 110/110 cum laude
Licensure 1995 Sapienza, University of Rome Qualification to practise as Medical Doctor. 106/110
Specialty 1999 Sapienza, University of Rome Post-graduate specialty in Infectious Diseases. 70/70 cum laude
Post-graduate course 2002 University of Texas Southwestern Medical Center Dallas MSc Master “Management of HIV infection”
PhD 2004 Sapienza, University of Rome Clinical and Experimental Immunoinfectivology. Cycle XVI
Post-graduate course 2008 Hospital San Carlos III, Madrid MSc Master “Management of HIV/HCV infection”
Post-graduate course 2009 American Society for Colposcopy and Cervical Pathology, Florida, USA MSc Master “High resolution anascopy”
Visitor Specialist 2009 University of San Francisco “Management of HPV infection”

Part III – Appointments

IIIA – Academic Appointments

Start End Institution Position
2000 2002 Italian National Institute of Health Research Scholarship focused on fighting against AIDS
2016 ongoing MIUR ASN-National Scientific Habilitation for Full Professor 06/D4, MEDS-10/B (ex MED/17)
2017 ongoing Sapienza, University of Rome Associate Professor in Infectious Diseases, 06/D4, MEDS-10/B (ex MED/17)
2018 ongoing Sapienza, University of Rome Member of Scientific Board of PhD Course in “Advances in Infectious Diseases, Microbiology, Legal Medicine and Public Health Sciences”
2018 ongoing Sapienza, University of Rome Member of Scientific Research Committee for Department of Public Health and Infectious Diseases
2024 ongoing Sapienza, University of Rome Member of Faculty committee of Pharmacy and Medicine Faculty
2024 ongoing Sapienza, University of Rome Member of Committee for the evaluation of Educational activities of Medicine and Surgery Course
2024 ongoing Azienda Policlinico Umberto I, Sapienza University of Rome Full Professor in Infectious Diseases, 06/D4, MEDS-10/B (ex MED/17)

IIIB – Other Appointments

Start End Institution Position
1995 2002 OMCEO (Association of Physician and Surgeons), Lecce Medical Doctor
2002 ongoing OMCEO (Association of Physician and Surgeons), Rome Medical Doctor (M51768)
2002 2004 Azienda Policlinico Umberto I Rome Coordinated and Continuous Collaborator (CoCoCo) for surveillance and prevention of nosocomial infections
2004 2017 Azienda Policlinico Umberto I Rome Medical director, Infectious Diseases Unit with fixed term contract (ex D.L.vo 368/01)
2017 2024 Azienda Policlinico Umberto I, Sapienza University of Rome Associate Professor in Infectious Diseases, 06/D4, MEDS-10/B (ex MED/17)
2024 ongoing Azienda Policlinico Umberto I, Sapienza University of Rome Full Professor in Infectious Diseases, 06/D4, MEDS-10/B (ex MED/17)
2025 ongoing Regional Coordination of Ethics Committees, Regione Lazio Member of the Ethics Committee Lazio Area 4, as Infectious Diseases Specialist

IIIC-Third mission events

Clinical Trial Study Involvement (coordination of clinical and experimental activities)
Clinical trial: Program Infectivology and movement: study of the effects of physical activity on HIV infection Primo) (Rif.2756) 2016

Clinical study: Role of HPV on life quality of HIV positive MSM (2018)

Clinical Study: Prevalence, risk factor and clinical outcome of invasive pulmonary aspergillosis in a cohort a patients with severe influenza SIGILLO STUDY (Rif. 5554) 2019

Clinical Study: Mortality and causes of death in HIV patients (Thanos) (Rif. 5681) 2020

Clinical Study: HIV aging population polypharmacy & interaction study- HAPPI STUDY (Rif. 5335) 2020

Clinical trial: Oral bacteriotherapy decontamination for the prevention of Ventilator Associated Pneumonia (VAP) in Intensive Care Unit patients.(Rif.6497) 2021

Clinical Study: Switching to BICTegravir/FTC/TAF STR from PI-based and/or NNRTI-based regimens in virologically suppressed HIV-infected ELderly patients: a retrospective data analysis. (BICTEL cohort) (Rif. 6199) 2021

Clinical Study: Non interventional observational retrospective study to evaluate doravirine based regimes in HIV infected aged patients (DORAge)(Rif. 6496) 2021

Clinical Study: Study of the innate and adaptive immune response in COVID-19 patients (RiaCovid-19) (Rif. 6484) 2021

Clinical study: A comprehensive analysis of CD4 and CD8 T regulatory cells in the pathogenesis of HIV and the effects of T reg axis on HIV latency (Rif. 6594) 2022

Clinical study:”Anti HIV Testing in Infectious Diseases and Emergency Wards” (Rif.6765) 2022

Clinical study: Pilot study on the characterization of molecular and cellular markers associated with sexually transmitted infections. (Rif.6963) 2022

Clinical Study: MIMOLA Study -Long term changes in MIcrobiota, Microbial translocation and Metaboloma (2023)

Clinical trial: “Phase 3b, multicenter, single-arm, open-label study to evaluate the efficacy, safety and tolerability of switching from the single-tablet regimen of bictegravir/emtricitabine/tenofovir alafenamide to the single-tablet regimen of DTG/3TC administered once once a day in people aged at least 50 with HIV who are virally suppressed" (2023)

Clinical study: INF-ACT (One Health Basic and Translational Research Actions addressing Unmet Needs on Emerging Infectious Diseases) (Rif. 7423) (2023)

Public Engagement activities
Teaching Book: “Medico di guardia: diagnosi e terapia” Casa editrice: IDELSON GNOCCHI. 2020
Participation at television program: “Misure di sicurezza per prevenire il contagio da Coronavirus”. TV 2000. 2020
Interactive and/or informative websites: "Grey patients diagnosed with COVID-19”. Italian Society of tropical and infectious diseases. 2020
Interactive and/or informative websites: "Grey patients diagnosed with COVID-19 Liceo Giulio Cesare. Febbraio 2020
Teaching Book:“Gestione clinica del paziente HIV+ anziano”. Edizione Minerva Medica. 2020
World AIDS Day “Fallo consapevole, fallo con Sapienza”. Sapienza, University, Roma. 2021
Interview: “Gestione clinica del paziente HIV+ anziano”. Pharmastar. 2021
Interview: “Gestione integrata del paziente HIV+” Il Sole 24 ore. 2021
Press Release: “Bacteriotherapy, a promising therapeutic strategy against the progression of COVID-19”. Sapienza, University Roma. 2021
“Non solo COVID: sensibilizzazione all’HIV e all’AIDS”. Sapienza, University Roma. 2021
Academic publication: “Global health”. NLD ED.2022
Interview: “Management of late HIV diagnoses”. Panorama della Sanità. 2022
Interview: “Management of late HIV diagnoses”Medical excellence TV. 2022
Interview “HIV and depression, the fight against stigma becomes a priority”. DiRE, national Press Agency . 2023
Interview: “World AIDS Day. HIV: almost half discover it by chance, two out of 10 do not share the news for fear of marginalization”. Sanità Informazione. 2023
Speaker at Updating training “FOCUS MULTIDISCIPLINARE SU HPV”. Order of Physicians Surgeons and Dentists of Roma. 2024
Tutor for orientation programme days at LUISS University, ROMA 2024
Interview: “la Sanità che vorrei” Ministry of Health. 2024
Teaching Book :” Emergencies and emergencies in infectivity”Idelson-Gnocchi-2024

Part IV – Teaching experience

Year Institution Lecture (Course)
2000-ongoing Sapienza, University of Rome Supplementary teaching activity with practical and technical exercises as part of the teaching course of Infectious Diseases at degree course in Medicine and Surgery and at specialization school in Infectious Diseases
2004-ongoing Private Istitution ECM courses in the field of Infectious Diseases
2009-2016 Policlinico Umberto I, Rome Master’s degree course in Assistance in the Operating Room – Instrumentalist (course code 14346)

2005-2016 Sapienza, University of Rome Course of Health Promotion and Safety (1st year 2nd semester) (Ministerial Decree 270/04) from the 2005-2006 academic year

2018-ongoing Sapienza, University of Rome PhD Course: "INFECTIOUS DISEASES, MICROBIOLOGY AND PUBLIC HEALTH"

2018-ongoing Sapienza, University of Rome Post Graduate Specialization School in Infectious and Tropical Diseases

2018-ongoing Sapienza, University of Rome Course of "Promotion of Health and Safety (course code 1036395)"

2018-ongoing Sapienza, University of Rome Course of Integrated Pathology V at Pharmacy and Medicine degree course (course code 1026328)

2018-ongoing Sapienza, University of Rome Medicine and Surgery “A” (qualifying the practice of the profession of Surgeon) - Rome Azienda Policlinico Umberto I LM-41 (course code 30891)

2019-ongoing Sapienza, University of Rome Course at Post Graduate Specialization School of Allergology and Clinical Immunology

2019-ongoing Sapienza, University of Rome Course of Internal Medicine and General Surgery II (course code 1023933)

2019-ongoing Sapienza, University of Rome Course at Post Graduate Specialization School in Microbiology and Virology

2020-2022 Sapienza, University of Rome Master in Molecular Virology

2023-ongoing Sapienza, University of Rome Course Coordinator in the HT degree in Integrated Pathology 2 and Biofluid Dynamics (course code 10595369)

Tutoring and coordination of the scientific activities of, PhD students, postgraduates and
undergraduate student from 2018 - today

Undergraduate 47
Postgraduate 10
PhD 8

Part V - Society memberships, Awards and Honors

Year Society memberships
2001 - ongoing Member of the Italian scientific Society of Infectious and Tropical diseases (SIMIT)
2013 Member of the Panel for the elaboration of oncology guidelines of Regione Lazio
2013 - ongoing Member of the Panel for the elaboration of Italian Guidelines on the use of Antiretroviral Therapy and diagnostic-clinical management
in people infected with HIV-1
2015 Member of the scientific committee of the ANLAIDS association
2018 - ongoing Member of the scientific committee for the awarding of the best manuscript published among young doctoral students of the Department of Public Health and Infectious Diseases, Sapienza, University of Rome- Italy
2020 Member of working group COVID-19 – SIMIT Lazio
2022 - ongoing Member of the board of SIMIT Regione Lazio

Awards and Honors

Year Title

2003
Award for best oral comunication - Conference of Italian Society of Tropical and Infectious Diseases- SIMIT held in Bologna

2016
Fellowship program Gilead 2016: ”Infectious Diseases and Movement Programme: Study of the effects of physical activity on HI infection” PRIMO

2016 Fellowship program Gilead 2016: Ethics award for the study: ”Infectious Diseases and Movement Programme: Study of the effects of physical activity on HI infection” PRIMO
2016 ICAR-CROI Awards_Mentor: “Rapid Improving of Glycemic Control in HCV Patients Treated with IFN-free Regimens”

2016 ICAR-CROI Awards_Mentor: “Probiotics Module Th1/Th17 and IFN Response in HIV Patients on Suppressive Cart”

2018 Fellowship program Gilead 2018: “ Role of HPV on life quality of HIV positive MSM”

2018 ICAR-CROI Awards_Mentor: “Cardiac ventricular disfunction in young vertically infected HIV patients”

2018 ICAR-CROI Awards_Mentor: “Beneficial effect of 6 months of probiotics on asymptomatic neurocognitive impairment”

2019 Memorial Maria Virginia Savoia: Award for the best thesis in “Gender Medicine” Faculty of Medicine and Dentistry Sapienza, University Rome-Italy

2019 ICAR-CROI Awards_Mentor: “Modulation of gut microbiota improves mucosal permeability in HIV+ patients”

2020 ICAR-CROI Awards_Mentor: “Prevotella is related to a dysregulation of IFN and T-CELL response in HIV infection”

2020 ICAR-CROI Awards_Mentor: “Functional restoring of gut barrier after modulation of intestinal microbiota”
2021 Fellowship program Gilead 2021: “A comprehensive analysis of CD4 and CD8 T regulatory cells in the pathogenesis of HIV and the effects of T reg axis on HIV latency”

2021 Award “Recti eques - Paladini della Salute Italiana” for the publication: “Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19”. Front Med (Lausanne). 2020 Jul 7;7:389. doi: 10.3389/fmed.2020.00389. eCollection 2020.PMID: 32733907- Campidoglio, Rome, Italy

2022 ICAR-CROI Awards_Mentor: “Gut barrier integrity and microbiota in HIV patients receiving oral bacteriotherapy”

2023 ICAR-CROI Awards_Mentor: “Increased burden of anal HPV-related potentially precancerous lesions in HIV+ women”

2023 ICAR-CROI Awards_Mentor: “Efficacy of late HPV vaccination in young HIV+ MSM”

2024 Award “Recti eques - Paladini della Salute Italiana” for the publication : “Reduced Reliability of Procalcitonin (PCT) as a Biomarker of Bacterial Superinfection: Concerns about PCT-Driven Antibiotic Stewardship in Critically Ill COVID-19 Patients-Results from a Retrospective Observational Study in Intensive Care Units”. J Clin Med. 2023 Sep 24;12(19):6171. doi: 10.3390/jcm12196171 Campidoglio, Rome, Italy

2024 ICAR-CROI Awards_Mentor: “Evaluation of the performance of different high resolution Anoscopy triage strategies in MSM LWH”

2024 ICAR-CROI Awards_Mentor: “Synergistic effects of HIV, HPV, and Polyomaviruses on interferon response in male anal mucosa”

Part VI - Funding Information [grants as PI-principal investigator or I-investigator]

Year Title Program Grant value
2016 Infectious Diseases and Movement Programme: study of the effects of physical activity on HIV infection- PRIMO

Principal investigator
Fellowship Program 2016-Gilead, Italy

€ 20,000
2016 Ethics Award: HIV infection

Principal investigator
Fellowship Program 2016-Gilead, Italy

€ 5,000
2018 Role of HPV on life quality of HIV positive MSM

Principal investigator Fellowship Program 2018-Gilead, Italy € 25,000
2018 Study of cardiovascular pathology in HIV-positive patients: clinical implications of changes in the microbiota and serological markers of immunoactivation

Principal investigator
Sapienza, University Rome-Italy € 10,000
2018 Correlation between circulating ANGPTL2 levels and immunoactivation status in a cohort of HIV-positive patients

Tutor Sapienza, University Rome-Italy € 1000,00
2018 Bacterial/viral interactions in infection and immunity: application of the flow cytometry technology in different clinical settings

Coinvestigator Sapienza, University Rome-Italy € 63,000
2019 Targeting endocrine, metabolic, and vascular dysfunction in HIV: pharmacological modulation of the phosphodiesterase type-5 in clinical and experimental models

Coinvestigator Sapienza, University Rome-Italy € 29,000
2020 Class III Biological Safety Cabinet as laboratory equipment for handling biological threat agents and monitoring host immune response to emerging infectious agents

Coinvestigator Sapienza, University Rome-Italy € 33,500
2020 Oral bacteriotherapy decontamination for the prevention of Ventilator Associated Pneumonia (VAP) in Intensive Care Unit patients

Principal investigator Sapienza, University Rome-Italy € 23,787
2020 Profilo della risposta immunitaria delle MBCs nel paziente COVID-19

Tutor Sapienza, University Rome-Italy € 2000,00
2020 Switching to BICTegravir/FTC/TAF STR from PI-based and/or NNRTI-based regimens in virologically suppressed HIV-infected ELderly patients: a retrospective data analysis. (BICTEL cohort)

Principal investigator
Grant Gilead , Italy € 50000,00
2021 High-parameter spectral cell sorting for the study of inflammation and immunity in metabolic diseases

Coinvestigator Sapienza, University Rome-Italy € 490.000
2021 Non interventional observational retrospective study to evaluate doravirine based regimes in HIV infected aged patients (DORAge)”.

Principal investigator Grant Merck Sharp & Dohme Corp. Italy € 70,000
2021 HIVAX: profilo della risposta anticorpale e delle cellule della memoria in pazienti con infezione da HIV vaccinati per Sars-CoV-2

Tutor
Sapienza, University Rome-Italy € 2000,00
2021 A comprehensive analysis of CD4 and CD8 T regulatory cells in the pathogenesis of HIV and the effects of T reg axis on HIV latency

Principal investigator Fellowship Program 2021-Gilead, Italy € 30000,00
2022 Anti HIV Testing in Infectious Diseases and Emergency Wards

Principal investigator Grant Gilead € 44860,00
2022 Enteral nutrition and GUT-BRAIN axis modulation in patients with anorexia nervosa: effects on neuropsychiatric condition, microbiota assessment, gut health, risk of microbial traslocation

Principal investigator Sapienza, University Rome-Italy € 10000,00
2022 Sex, immunity and microbiome: the relationship between GUT T cell response, microbiota composition and gender in HIV-1 infected individuals

Tutor Sapienza, University Rome-Italy € 2000,00
2022 Ultrasensitive digital platform as a breakthrough technology to detect and quantify disease surrogate biomarkers in different clinical settings.

Coinvestigator Sapienza, University Rome-Italy € 48,175
2022 One Health Basic and Translational Research actions addressing Unmeet needs on Emerging Infectious Diseases (INFACT)

Component of critical mass Sapienza – Spoke 1 National Recovery and Resilience Plan (NRRP) Emerging Infectious diseases
€ 50,000
2023 Innovative approaches to improve diagnosis , outcome, surveillance, epidemiology and therapy of infectious diseases

Coinvestigator Sapienza, University Rome-Italy € 51.870
2024 BICTEL cohort: long term follow up and CD4 CD8 recovery in older PWH
Principal investigator Grant Gilead € 33000,00

Part VII – Research Activities

Prof. Gabriella d'Ettorre is a senior clinician scientist with an internationally competitive research, training, and education profile. She has a world-class track record in clinical translational research and a proven ability to attract substantial extramural research funding. Prof. d'Ettorre also maintains a primary care clinic for patients with viral and bacterial infections and has contributed significantly to developing state-of-the-art Infectious Diseases clinical services at Policlinico Umberto I Hospital.
Her research group focuses on translational medicine, aiming to identify therapeutic strategies and the mechanisms underlying the pathogenesis of HIV. They are particularly interested in global health, high-consequence infectious diseases, and complex viral infections such as HIV, HPV, and SARS-CoV-2, as well as respiratory infections, including novel strains and variants of Influenza and other emerging viruses.
Prof. d'Ettorre's work is impactful and highly credible, thanks to her collaborations with renowned US institutions such as the University of Atlanta, NIH in Maryland, and San Francisco Mount Sinai Hospital. These collaborations allow her to utilize her scientific findings to continue translational research, identifying innovative therapies and pathogenetic mechanisms of HIV infection. Her ability to work with such esteemed partners is a testament to the quality and significance of her research.
In 2015, Prof. d'Ettorre and her NIH colleagues published ground-breaking data on the use of specific probiotics in HIV treatment. Since then, she has led a dedicated research group, publishing several scientific articles on the therapeutic potential of probiotics in HIV and the underlying pathophysiological mechanisms. Her innovative approach has not only advanced our understanding of HIV co-treatments but also inspired others in the field. Concurrently, she continues her research in the fields of hepatitis, HPV infection, publishing numerous works in collaboration with major Italian clinical centers. Prof. d'Ettorre's capacity for collaboration, data sharing, and coordination of scientific resources is evident in her participation in several scientific boards and her significant continuity in scientific production.

Keywords Brief description
Improvement management of fragile patients Prof d'Ettorre publications highlights how crucial efficient communication strategies are for preventing illness in HIV prevention and treatment. By using a patient-centred approach, she has achieved substantial strides in the effectiveness of long-term antiretroviral treatment. Her investigation on the relationship between COVID-19 and HIV has shed important light on the way co-infections affect immune responses. She investigated immunological and inflammatory responses in COVID-19, concentrating on genetic polymorphisms and blood biomarkers. She also emphasized the pandemic's effects on survivors and healthcare workers' post-traumatic stress disorder in particular, as well as their cognitive and mental health. According to the results of the research, the modulation of microbiota can effectively heal infections, lessen chronic fatigue, and enhance HIV patients' immune recovery. Her research on the epidemiology, management, and occupational health of influenza and influenza-like illnesses has yielded important insights into public health strategies, cellular functions, immunological responses, and difficult-to-treat infections.

Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort.
Lazzaro A, Bianchini D, Gentilini Cacciola E, Mezzaroma I, Falciano M,
Andreoni C, Fimiani C, Santinelli L, Maddaloni L, Bugani G, Ceccarelli G,
Mastroianni CM, d'Ettorre G. Viruses. 2023 May 23;15(6):1222. doi: 10.3390/v15061222. PMID: 37376522; PMCID: PMC10302527

Post-Traumatic Stress Disorder Trajectories the Year after COVID-19 Hospitalization. Serra R, Borrazzo C, Vassalini P, Di Nicolantonio C, Koukopoulos AE, Tosato C, Cherubini F, Alessandri F, Ceccarelli G, Mastroianni CM, D'Ettorre G, Tarsitani L. Int J Environ Res Public Health. 2022 Jul 11;19(14):8452. doi: 10.3390/ijerph19148452. PMID: 35886306; PMCID: PMC9316829

Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients.
Santinelli L, Laghi L, Innocenti GP, Pinacchio C, Vassalini P, Celani L, Lazzaro A, Borrazzo C, Marazzato M, Tarsitani L, Koukopoulos AE, Mastroianni CM, d'Ettorre G, Ceccarelli G.Front Nutr. 2022 Jan 12;8:756177. doi: 10.3389/fnut.2021.756177. eCollection 2021.
PMID: 35096923 Free PMC article

Microbial and metabolic research Prof. d'Ettorre has been actively involved in pioneering research in the field of new experimental treatments for infectious diseases, particularly HIV and COVID-19. Her research has studied the efficacy of monoclonal antibodies in modulating the immune response in COVID-19 patients and has analyzed patient outcomes based on different therapeutic approaches. She has also made important contributions to our understanding of the role of type 1 interferons and the complex genetic polymorphisms that affect these signaling pathways. Another focus of her research is the management of the gut microbiota to improve immune function and reduce fatigue in patients with these viral infections. Her work on superinfections in critically ill patients with COVID-19 highlights the complexity of managing these conditions and the importance of early detection and treatment coordination to improve patient outcomes.

Differential expression of Type I interferon and inflammatory genes in SARS-CoV-2-infected patients treated with monoclonal antibodies. Maddaloni L, Santinelli L, Bugani G, Cacciola EG, Lazzaro A, Lofaro CM, Caiazzo S, Frasca F, Fracella M, Ajassa C, Leanza C, Napoli A, Cinti L, Gaeta A,Antonelli G, Ceccarelli G, Mastroianni CM, Scagnolari C, d'Ettorre G. Immun Inflamm Dis.2023 Oct;11(10):e968. doi: 10.1002/iid3.968. PMID: 37904704; PMCID: PMC10571496

Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients.Trinchieri V, Marazzato M, Ceccarelli G, Lombardi F, Piccirilli A, Santinelli L, Maddaloni L, Vassalini P, Mastroianni CM, d'Ettorre G. Biomedicines. 2022 Aug 1;10(8):1851. doi: 10.3390/biomedicines10081851. PMID: 36009399; PMCID: PMC9405060

Viral community acquired pneumonia at the emergency department: Report from the pre COVID-19 age. Spagnolello O, Pierangeli A, Cedrone MC, Di Biagio V, Gentile M, Leonardi A, Valeriano C, Innocenti GP, Santinelli L, Borrazzo C, Russo A, Oliveto G, Viscido A, Ciccozzi M, Bertazzoni G, d'Ettorre G, Ceccarelli G. J Med Virol. 2021 Jul;93(7):4399-4404. doi: 10.1002/jmv.26980. Epub 2021 Apr 6.PMID: 33783850

Immunopathogenesis Prof. d’Ettorre has extensively studied the immunopathogenesis and cellular mechanisms involved in infectious diseases, particularly HIV and COVID-19. Her work has highlighted the critical role of type 1 and type 3 interferons in the immune response to SARS-CoV-2, clarifying how these responses differ between co-infected patients and those treated with monoclonal antibodies. She has investigated genetic polymorphisms and blood biomarkers that regulate these responses, providing insights into the inflammatory pathways activated during infection. Prof. d'Ettorre is also investigating the role of gut microbiota and probiotics in modulating immune recovery and reducing chronic fatigue in HIV and COVID-19 patients, highlighting the relationship between gut barrier disruption, mitochondrial dysfunction, and immune activation. She has studied cellular immune profiles in the lungs and blood of COVID-19 patients, yielding important findings on the differential expression of interferons and inflammatory genes, advancing our understanding of the complex interplay between host and pathogen defense mechanisms.

The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with HIV.
Santinelli L, Rossi G, Gioacchini G, Verin R, Maddaloni L, Cavallari EN,Lombardi F, Piccirilli A, Fiorucci S, Carino A, Marchianò S, Lofaro CM, Caiazzo S, Ciccozzi M, Scagnolari C, Mastroianni CM, Ceccarelli G, d'Ettorre G. J Med Virol. 2023 Jan;95(1):e28402. doi: 10.1002/jmv.28402. PMID: 36515414

Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω.
Pierangeli A, Gentile M, Oliveto G, Frasca F, Sorrentino L, Matera L, Nenna R, Viscido A, Fracella M, Petrarca L, D'Ettorre G, Ceccarelli G, Midulla F, Antonelli G, Scagnolari C. Front Immunol. 2022 Jul 12;13:873232. doi: 10.3389/fimmu.2022.873232. eCollection 2022

Cellular Immune Profiling of Lung and Blood Compartments in
Patients with SARS-CoV-2 Infection. Santinelli L, Lazzaro A, Sciarra F, Maddaloni L, Frasca F, Fracella M, Moretti S, Borsetti A, Bugani G, Alessandri F, Zullino V, Ruberto F, Pugliese F, Sorrentino L, Gianfrilli D, Isidori A, Venneri MA, Mastroianni CM, Ceccarelli G, d'Ettorre G. Pathogens. 2023 Mar 11;12(3):442. doi: 10.3390/pathogens12030442. PMID: 36986364; PMCID: PMC10057444.IF 3.3 Cit. scopus 3

Invited speaker at national or international congresses

Year Conference
1999 Interscience on Antimicrobial Agents and Chemotherapy (ICAAC)"- Washington, USA
2001 1st IAS Conference on HIV Pathogenesis and treatment" Buenos Aires
2002 National Conference ANLAIDS - Torino
2004 XV International AIDS Conference" – Bangkok
2004 National Conference ANLAIDS - Roma
2005 3rd IAS Conference on AIDS Pathogenesis and Treatment" Rio de Janeiro
2005 National Conference Anlaids -Vibo Valentia
2010 XII International Meeting of Virology -Tropea
From 2011- today ICAR (Italian Conference on Aids and Antiviral Research
2013 National Conference of Immunology - Ancona
2014 SIVIM (Italian Society of Virology)
2016 4th world congress on targeting microbiota - Istituto Pasteur, Parigi
2017 3rd International Workshop on Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment, Rockville, Maryland, USA
2019-today SIMIT (National Italian Conference of infectious and tropical diseases)
2019 Digestive Disease Week®, San Diego Convention Center, San Diego, USA
2024 51° National Conference AMCLI (Association of Italian Clinical Microbiologists)

VII- Editorial Board member and Associate editor of International Journals peer reviewed

Journal
Position
The Open AIDS Journal Editorial Board Member

Sexes Editorial Board Member

Journal of HIV and Ageing Associate Editor

Current HIV Research
Editorial Board Member
Frontiers in Molecular Biosciences Associate Editor

Frontiers in Virology
Associate Editor
Pathogens Board Member

Infectious Diseases and Tropical Medicine - Board Member

Microorganisms Editorial Board Member

Guest Editor in Special Issue

Journal Title
Nutrients Nutrition and HIV/AIDS
Biomedicines New Advances in Pathogenesis and Treatment of HIV Infection: Molecular Insight and Preclinic Research
Microorganisms Pathogenetic Mechanisms and Innovative Therapies for Viral, Bacterial and Fungal Infections
International Journal of Molecular Sciences Drug Development in the Prevention and Treatment of COVID-19
International Journal of Microbiology Microbial Translocation and Infectious Diseases: What Is the Link?
Nutrients Nutrition and HIV/AIDS
Biomedicines New Advances in Pathogenesis and Treatment of HIV Infection: Molecular Insight and Preclinic Research
Microorganisms Pathogenetic Mechanisms and Innovative Therapies for Viral, Bacterial and Fungal Infections

Part VIII – Summary of Scientific Achievements

Product type Number Data base Start End
Papers (international) 297 Scopus, Pubmed 1999 2024
Books chapters (scientific) 2 ISBN 2018 2020
Books (teaching) 1 ISBN 2024 2024
Books chapters (scientific) 5 ISBN 2005 2024
Encyclopedia entry 2 ISBN 2005 2008

Total Impact factor 1258,79
Average Impact factor 4,23
Total Citations 5520
Average Citations per Product 18,58
Hirsch (H) index 39
Normalized H index* 1,5

*H index divided by the academic seniority.

Book – Chapter-Encyclopedia entry Title
Idelson Gnocchi, 2024 – ISBN 978-88-79478083 Urgenze ed emergenze in Infettivologia
Idelson Gnocchi, 2024 – ISBN 978-88-79477963 Medico di Guardia: Diagnosi e terapia 2020
Minerva Medica 2020 ISBN: 978-88-553-2042-9 COVID-19
Edra, 2020 ISBN: 978-88-214-5111-9 Manuale di Malattie Infettive

Elsier Masson, 2015 ISBN: 978-88-214-3972-8
Manuale di malattie infettive
India, Studium Press LLC – ISBN 10: 1626991103 Probiotics in HIV infection.
Elsier Masson,2009 ISBN: 978882143972-8, Manuale di malattie infettive

Biomedia, 2009 ISBN: 9788886154451, Manuale di infettivologia neonatale

Encicloedia Medica Italiana, 2008 UTET, “Infezioni nosocomiali, oxazolidinoni,streptogramine, telitromicina,
tigeciclina”

Treccani, 2005 “Infezione, batteri, antbiotici, virus, colera, AIDS”

List of publications in international journals

Chronic Viral Infections and Al Amyloidosis: An Uncommon Association. Palladini A, Cusumano G, Martellucci O, Gigante A, D'Ettorre G, Petrucci MT, Muscaritoli M, Palladino M. Clin Case Rep. 2025 Apr 2;13(4):e9616. doi: 10.1002/ccr3.9616.
The added value of diagnostics to characterize age-specific patterns of respiratory viral infections and coinfections and to detect emerging threats. Pierangeli A, Turriziani O, Fracella M, Campagna R, Frasca F, D'Auria A, Scagnolari C, Roberto P, Cinti L, D'Ettorre G, Ceccarelli G, Petrarca L, Nenna R, Midulla F, Galardo G, Antonelli G. BMC Infect Dis. 2025 Mar 25;25(1):404. doi: 10.1186/s12879-025-10693-0.
Taramasso L, Rossotti R, Tavelli A, Santoro MM, Mazzotta V, Bandera A, D'Ettorre G, Milano E, Pellicano GF, Baiguera C, Bruzzesi E, D'Arminio Monforte A, Antinori A, Nozza S; ICONA Foundation Study Group. Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort. J Acquir Immune Defic Syndr. 2025 Apr 1;98(4):352-356. doi: 10.1097/QAI.0000000000003576.
Efficacy, safety, and anti-inflammatory properties of the switch to a doravirine-based regimen among antiretroviral-experienced elderly people living with HIV-1: the DORAGE cohort. Lazzaro A, Recchia GE, Alessi F, Santinelli L, Battistini L, Morcos J, Romano F, Bugani G, Maddaloni L, Caruso S, D'Amico M, Mezzaroma I, Falciano M, Fimiani C, Sfara G, Leone MG, Turriziani O, Mastroianni CM, d'Ettorre G. Antimicrob Agents Chemother. 2025 Apr 2;69(4):e0081524. doi: 10.1128/aac.00815-24.
A family cluster of persistent Pandoraea vervacti infection in cystic fibrosis. Bitossi C, Fracella M, Viscido A, Diaco F, Pecoraro C, Troiani P, Cimino G, d'Ettorre G, Trancassini M, Pierangeli A, Antonelli G, Scagnolari C. J Immunoassay Immunochem. 2025 Mar 4;46(2):201-206. doi: 10.1080/15321819.2025.2462807.
Gut TLRs and IFN pathways mRNA expression and frequencies of CD4+T cell expressing CD38 or HLA-DR go in parallel during HIV immunopathogenesis. Maddaloni L, Bugani G, Santinelli L, Lazzaro A, Frasca F, Fracella M, Ceccarelli G, Mastroianni CM, Scagnolari C, d'Ettorre G. Immunol Lett. 2025 Apr;272:106973. doi: 10.1016/j.imlet.2025.106973.
Breaking Down Bone Disease in People Living with HIV: Pathophysiology, Diagnosis, and Treatment. Hasenmajer V, D'Addario NF, Bonaventura I, Sada V, Nardi C, Jannini EA, D'Ettorre G, Mastroianni C, Gianfrilli D. Adv Exp Med Biol. 2024 Dec 13. doi: 10.1007/5584_2024_831.
Rethinking scabies in Europe: An ECDC prevention framework approach. Ceccarelli G, Branda F, Scarpa F, Albanese M, d'Ettorre G, Giovanetti M, Ciccozzi M. Travel Med Infect Dis. 2025 Jan-Feb;63:102786. doi: 10.1016/j.tmaid.2024.102786.
MPXV infection impairs IFN response but is partially sensitive to IFN-γ antiviral effect. Bordi L, D'Auria A, Frasca F, Mazzotta V, Mazzetti P, Fracella M, d'Ettorre G, Antonelli G, Pistello M, Antinori A, Viscidi RP, Maggi F, Lalle E, Scagnolari C. Med Microbiol Immunol. 2024 Nov 11;213(1):25. doi: 10.1007/s00430-024-00808-w.
Reassessing the Risk of Severe Parvovirus B19 Infection in the Immunocompetent Population: A Call for Vigilance in the Wake of Resurgence. Ceccarelli G, Branda F, Ciccozzi A, Romano C, Sanna D, Casu M, Albanese M, Alessandri F, d'Ettorre G, Ciccozzi M, Scarpa F, Giovanetti M. Viruses. 2024 Aug 24;16(9):1352. doi: 10.3390/v16091352.
Outcomes of severe aspergillosis in patients undergoing extracorporeal membrane oxygenation: A systematic review.Alessandri F, Giordano G, Sanda VC, D'Ettorre G, Pugliese F, Ceccarelli G. Artif Organs. 2025 Mar;49(3):362-372. doi: 10.1111/aor.14871.
Beyond one size fits all: tailoring healthcare to the realities of migration. Ceccarelli G, Branda F, Giovanetti M, d'Ettorre G, Scarpa F, Ciccozzi M. Lancet Reg Health Eur. 2024 Aug 31;45:101058. doi: 10.1016/j.lanepe.2024.101058.
High rates of anal Merkel Cell Polyomavirus and HPV co-infection among people living with HIV. Passerini S, Fracella M, Benvenuto D, Bugani G, D'Auria A, Coratti E, Babini G, Moens U, Cavallari EN, Torti C, Antonelli G, Ciccozzi M, Pierangeli A, d'Ettorre G, Scagnolari C, Pietropaolo V. J Med Virol. 2024 Aug;96(8):e29883. doi: 10.1002/jmv.29883.
An Update on the Entomology, Virology, Pathogenesis, and Epidemiology Status of West Nile and Dengue Viruses in Europe (2018-2023). Frasca F, Sorrentino L, Fracella M, D'Auria A, Coratti E, Maddaloni L, Bugani G, Gentile M, Pierangeli A, d'Ettorre G, Scagnolari C. Trop Med Infect Dis. 2024 Jul 20;9(7):166. doi: 10.3390/tropicalmed9070166.
Assessing ChatGPT's Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity. De Vito A, Colpani A, Moi G, Babudieri S, Calcagno A, Calvino V, Ceccarelli M, Colpani G, d'Ettorre G, Di Biagio A, Farinella M, Falaguasta M, Focà E, Giupponi G, Habed AJ, Isenia WJ, Lo Caputo S, Marchetti G, Modesti L, Mussini C, Nunnari G, Rusconi S, Russo D, Saracino A, Serra PA, Madeddu G. AIDS Behav. 2024 Jun 5. doi: 10.1007/s10461-024-04391-2. Epub ahead of print. PMID: 38836986.
Occupational Risk for Coronary Artery Disease in Shift Workers - A Systematic Review. D'Ettorre G, Piscitelli P, Pellicani V, Tornese R, Ceccarelli G, D'Ettorre G, La Torre G. Med Lav. 2024 Apr 24;115(2):e2024015. doi: 10.23749/mdl.v115i2.15532. PMID: 38686577; PMCID: PMC11181222.
Resting-state EEG rhythms are abnormal inpost COVID-19 patients with brain fog without cognitive and affective disorders. Babiloni C, Gentilini Cacciola E, Tucci F, Vassalini P, Chilovi A, Jakhar D,Musat AM, Salvatore M, Soricelli A, Stocchi F, Vacca L, Ferri R, Catania V,
Mastroianni C, D'Ettorre G, Noce G. Clin Neurophysiol. 2024 Mar 6;161:159-172. doi: 10.1016/j.clinph.2024.02.034. Epub ahead of print. PMID: 38492271.
The Epidemiology of Anal Human Papillomavirus (HPV) in HIV-Positive and HIV-Negative Women and Men: A Ten-Year Retrospective Observational Study in Rome (Italy). Fracella M, Oliveto G, Roberto P, Cinti L, Gentile M, Coratti E, D'Ettorre G, Cavallari EN, Romano F, Santinelli L, Maddaloni L, Frasca F, Scagnolari C, Antonelli G, Pierangeli A. Pathogens. 2024 Feb 11;13(2):163. doi:10.3390/pathogens13020163. PMID: 38392901; PMCID: PMC10892302.
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? Colpani A, De Vito A, Zauli B, Menzaghi B, Calcagno A, Celesia BM, Ceccarelli M, Nunnari G, De Socio GV, Di Biagio A, Leoni N, Angioni G, Giambenedetto SD,
D'Ettorre G, Babudieri S, Madeddu G. Healthcare (Basel). 2024 Feb 6;12(4):417. doi: 10.3390/healthcare12040417. PMID: 38391793; PMCID: PMC10888293.
Optimizing the antiretroviral treatment focusing on long-term effectiveness and
a person-centered approach. Consensus Guidance Using a Delphi Process. Maggiolo F, Lo Caputo S, Bonora S, Borderi M, Cingolani A, D'Ettorre G, Di Biagio A, Di Giambenedetto S, Gervasoni C, Guaraldi G, Maggi P, Taramasso L. New Microbiol. 2024 Jan;46(4):367-380. PMID: 38252048.
Early recognition of a superinfection: This is the problem in the critically ill COVID-19 patients. Alessandri F, d'Ettorre G, Ciccozzi M, Migliara G, Baccolini V, Pugliese F,Ceccarelli G. J Med Virol. 2024 Jan;96(1):e29345. doi:10.1002/jmv.29345. PMID: 38148715.
Right to Occupational Safety: Prevalence of Latent Tuberculosis Infection in Healthcare Workers. A 1-Year Retrospective Survey Carried out at Hospital of Lecce (Italy). d'Ettorre G, Karaj S, Piscitelli P, Maiorano O, Attanasi C, Tornese R, Carluccio E, Giannuzzi P, Greco E, Ceccarelli G, d'Ettorre G, Lobreglio G, Congedo P, Broccolo F, Miani A. Epidemiologia (Basel). 2023 Oct
31;4(4):454-463. doi: 10.3390/epidemiologia4040038. PMID: 37987310; PMC10660459
Differential expression of Type I interferon and inflammatory genes in SARS-
CoV-2-infected patients treated with monoclonal antibodies. Maddaloni L, Santinelli L, Bugani G, Cacciola EG, Lazzaro A, Lofaro CM, Caiazzo S, Frasca F, Fracella M, Ajassa C, Leanza C, Napoli A, Cinti L, Gaeta A,Antonelli G, Ceccarelli G, Mastroianni CM, Scagnolari C, d'Ettorre G. Immun Inflamm Dis.2023 Oct;11(10):e968. doi: 10.1002/iid3.968. PMID: 37904704; PMCID: PMC10571496.
Parietal resting-state EEG alpha source connectivity is associated with
subcortical white matter lesions in HIV-positive people.
Babiloni C, Del Percio C, Piervincenzi C, Carducci F, Ferri R, Onorati P,
Toma G, Ferracuti S, Roma P, Correr V, Di Campli F, Aceti A, Salvatore M,
Soricelli A, Teti E, Pennica A, Sarmati L, Vullo V, D'Ettorre G, Mastroianni C,
Petsas N, Pantano P, Floris R, Stocchi F, Andreoni M, Di Perri G, Calcagno A,
Noce G. Clin Neurophysiol. 2023 Sep 30;156:19-27. doi: 10.1016/j.clinph.2023.09.006. Epub ahead of print. PMID: 37844524.
Reduced Reliability of Procalcitonin (PCT) as a Biomarker of Bacterial Superinfection: Concerns about PCT-Driven Antibiotic Stewardship in Critically Ill COVID-19 Patients-Results from a Retrospective Observational Study in Intensive Care Units.
Ceccarelli G, Alessandri F, Migliara G, Baccolini V, Giordano G, Galardo G,
Marzuillo C, De Vito C, Russo A, Ciccozzi M, Villari P, Venditti M, Mastroianni
CM, Pugliese F, d'Ettorre G.
J Clin Med. 2023 Sep 24;12(19):6171. doi: 10.3390/jcm12196171. PMID: 37834815; PMCID: PMC10573961.
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study.
Lagi F, Giacomelli A, Borghi V, Ciccullo A, Taramasso L, Madeddu G, D'Ettorre G, Giacometti A, Ducci F, De Vito A, Pincino R, Di Giambenedetto S, Mussini C,
Antinori S, Sterrantino G.
J Med Virol. 2023 Oct;95(10):e29149. doi: 10.1002/jmv.29149. PMID: 37805832
Pillars of long-term antiretroviral therapy success.
Taramasso L, Andreoni M, Antinori A, Bandera A, Bonfanti P, Bonora S, Borderi
M, Castagna A, Cattelan AM, Celesia BM, Cicalini S, Cingolani A, Cossarizza A,
D'Arminio Monforte A, D'Ettorre G, Di Biagio A, Di Giambenedetto S, Di Perri G,
Esposito V, Focà E, Gervasoni C, Gori A, Gianotti N, Guaraldi G, Gulminetti R,
Lo Caputo S, Madeddu G, Maggi P, Marandola G, Marchetti GC, Mastroianni CM,
Mussini C, Perno CF, Rizzardini G, Rusconi S, Santoro M, Sarmati L, Zazzi M,
Maggiolo F. Pharmacol Res.2023 Oct;196:106898. doi: 10.1016/j.phrs.2023.106898. Epub 2023 Aug 28. PMID:37648103.
MicroRNA Expression Levels in Peripheral Blood Mononuclear Cells from Human
Immunodeficiency Virus Type 1 Positive Individuals and Relationship with
Different Levels of Viral Suppression. Di Carlo D, Falasca F, Mazzuti L, Guerrizio G, Migliara G, Santori M, Lazzaro A, Mezzaroma I, D'Ettorre G, Fimiani C, Iaiani G, Antonelli G, Turriziani O.
AIDS Res Hum Retroviruses. 2023 Jul 31. doi: 10.1089/aid.2022.0165. Epub ahead of print. PMID: 37523231.
Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH: A 96 Week Update from the BICTEL Cohort.
Lazzaro A, Bianchini D, Gentilini Cacciola E, Mezzaroma I, Falciano M,
Andreoni C, Fimiani C, Santinelli L, Maddaloni L, Bugani G, Ceccarelli G,
Mastroianni CM, d'Ettorre G. Viruses. 2023 May 23;15(6):1222. doi: 10.3390/v15061222. PMID: 37376522; PMCID: PMC10302527.

Chronic Suppressive Antibiotic Treatment for Staphylococcal Bone and Joint
Implant-Related Infections. Ceccarelli G, Perciballi B, Russo A, Martini P, Marchetti F, Capparuccia MR, Iaiani G, Fabris S, Ciccozzi M, Villani C, Venditti M, D'Ettorre G, De Meo D.
Antibiotics (Basel). 2023 May 21;12(5):937. doi: 10.3390/antibiotics12050937. PMID: 37237840; PMCID: PMC10215711.
Comment on: Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study. Ciccullo A, Baldin G, Sterrantino G, Madeddu G, D'ettorre G, Mussini C, Di Giambenedetto S. J Antimicrob Chemother. 2023 Jul 5;78(7):1808-1809. doi: 10.1093/jac/dkad151. PMID: 37220765.
Cellular Immune Profiling of Lung and Blood Compartments in
Patients with SARS-CoV-2 Infection. Santinelli L, Lazzaro A, Sciarra F, Maddaloni L, Frasca F, Fracella M, Moretti S, Borsetti A, Bugani G, Alessandri F, Zullino V, Ruberto F, Pugliese F,
Sorrentino L, Gianfrilli D, Isidori A, Venneri MA, Mastroianni CM, Ceccarelli G,
d'Ettorre G. Pathogens. 2023 Mar 11;12(3):442. doi:
10.3390/pathogens12030442. PMID: 36986364; PMCID: PMC10057444.
Alterations in the Expression of IFN Lambda, IFN Gamma and Toll-like Receptors in Severe COVID-19 Patients. Sorrentino L, Fracella M, Frasca F, D'Auria A, Santinelli L, Maddaloni L, Bugani G, Bitossi C, Gentile M, Ceccarelli G, Turriziani O, Mastroianni CM, Antonelli G, d'Ettorre G, Pierangeli A, Scagnolari C. Microorganisms. 2023 Mar 8;11(3):689. doi:10.3390/microorganisms11030689. PMID: 36985262; PMCID: PMC10058642.
The presence of resistance-associated mutations in reverse transcriptase gene is
associated with cerebrospinal fluid HIV-1 escape: A multicentric retrospective
analysis. Trunfio M, Pinnetti C, Arsuffi S, Bai F, Celani L, D'Ettorre G, Vera JH,
D'Arminio Monforte A, Focà E, Ghisetti V, Bonora S, Antinori A, Calcagno A.
J Med Virol. 2023 Apr;95(4):e28704. doi: 10.1002/jmv.28704. PMID:
36967541.
High Incidence of Candidemia in Critically Ill COVID-19 Patients Supported by Veno-Venous Extracorporeal Membrane Oxygenation: A Retrospective Study.
Alessandri F, Ceccarelli G, Migliara G, Baccolini V, Russo A, Marzuillo C,
Ceparano M, Giordano G, Tozzi P, Galardo G, Raponi G, Mastroianni C, Venditti M,
Pugliese F, d'Ettorre G.
J Fungi (Basel). 2023 Jan 14;9(1):119. doi:10.3390/jof9010119. PMID: 36675940; PMCID: PMC9861971.
The crosstalk between gut barrier impairment, mitochondrial dysfunction, and
microbiota alterations in people living with HIV.
Santinelli L, Rossi G, Gioacchini G, Verin R, Maddaloni L, Cavallari EN,Lombardi F, Piccirilli A, Fiorucci S, Carino A, Marchianò S, Lofaro CM, Caiazzo S, Ciccozzi M, Scagnolari C, Mastroianni CM, Ceccarelli G, d'Ettorre G. J Med Virol. 2023 Jan;95(1):e28402. doi: 10.1002/jmv.28402. PMID: 36515414.
Health-related quality of life in survivol of severe COVID-19 infection. D’Ettorre G, Vassalini P, Coppolelli V, Gentilini CacciolaE, Santinelli L, Maddaloni L, Fabris S, Mastroianni CM, d’Ettorre G, Ceccarelli G.
Pharmacol Rep. 2022 Dec; 74 (6) : 1286-1295.DOI: 10.1007/s43440-022-00433-5.
Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients. Stefanini L, Ruberto F, Curreli M, Chistolini A, Schiera E, Marrapodi R, Visentini M, Ceccarelli G, D'Ettorre G, Santoro C, Gandini O, Moro EF, Zullino V, Pugliese F, Pulcinelli FM. Thromb Haemost. 2023 Jan;123(1):118-122. doi: 10.1055/a-1962-5447. Epub 2022 Oct 17. PMID: 36252812; PMCID: PMC9831687.
Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects.Zuccalà P, Latronico T, Marocco R, Savinelli S, Vita S, Mengoni F, Tieghi T, Borgo C, Kertusha B, Carraro A, D'Ettorre G, Vullo V, Mastroianni CM, Liuzzi GM, Lichtner M. Int J Mol Sci. 2022 Oct 8;23(19):11936. doi: 10.3390/ijms231911936. PMID: 36233234; PMCID: PMC9570033.
Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe Trauma. Ceccarelli G, Alessandri F, Moretti S, Borsetti A, Maggiorella MT, Fabris S, Russo A, Ruberto F, De Meo D, Ciccozzi M, Mastroianni CM, Venditti M, Pugliese F, d'Ettorre G. Pathogens. 2022 Nov 4;11(11):1295. doi: 10.3390/pathogens11111295. PMID: 36365046; PMCID: PMC9695038.
Time to Effective Therapy Is an Important Determinant of Survival in Bloodstream Infections Caused by Vancomycin-Resistant Enterococcus spp. Russo A, Picciarella A, Russo R, d'Ettorre G, Ceccarelli G. Int J Mol Sci. 2022 Oct 7;23(19):11925. doi: 10.3390/ijms231911925. PMID: 36233227; PMCID: PMC9570353.
Rates and Determinants of Hospital-Acquired Infection among ICU Patients Undergoing Cardiac Surgery in Developing Countries: Results from EMERGENCY'NGO's Hospital in Sudan. Spagnolello O, Fabris S, Portella G, Raafat Shafig Saber D, Giovanella E, Badr Saad M, Langer M, Ciccozzi M, d'Ettorre G, Ceccarelli G. Antibiotics (Basel). 2022 Sep 9;11(9):1227. doi: 10.3390/antibiotics11091227. PMID: 36140005; PMCID: PMC9494959.
Depressive Symptoms among Individuals Hospitalized with COVID-19: Three-Month Follow-Up. Vassalini P, Serra R, Tarsitani L, Koukopoulos AE, Borrazzo C, Alessi F, Di Nicolantonio C, Tosato C, Alessandri F, Ceccarelli G, Mastroianni CM, d'Ettorre G. Brain Sci. 2021 Sep 5;11(9):1175. doi: 10.3390/brainsci11091175. PMID: 34573196; PMCID: PMC8471767.
SARS-CoV-2 pandemic, influenza, and influenza-like illness epidemics: Allies or enemies? Ceccarelli G, d'Ettorre G, Russo A, Fabris S, Ciccozzi M, d'Ettorre G. J Med Virol. 2023 Jan;95(1):e28148. doi: 10.1002/jmv.28148. Epub 2022 Sep 21. PMID: 36114792; PMCID: PMC9538197.
The Mutual Relationship among Cardiovascular Diseases and COVID-19: Focus on Micronutrients Imbalance. Severino P, D'Amato A, Prosperi S, Myftari V, Labbro Francia A, Önkaya M, Notari C, Papisca I, Canuti ES, Yarden Revivo M, Birtolo LI, Celli P, Galardo G, Maestrini V, d'Ettorre G, Mancone M, Fedele F. Nutrients. 2022 Aug 21;14(16):3439. doi: 10.3390/nu14163439. PMID: 36014944; PMCID: PMC9416353.
Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients.Trinchieri V, Marazzato M, Ceccarelli G, Lombardi F, Piccirilli A, Santinelli L, Maddaloni L, Vassalini P, Mastroianni CM, d'Ettorre G. Biomedicines. 2022 Aug 1;10(8):1851. doi: 10.3390/biomedicines10081851. PMID: 36009399; PMCID: PMC9405060.
Efficacy of antiseptic mouthrinses against SARS-CoV-2: A prospective randomized placebo-controlled pilot study. Fantozzi PJ, Pampena E, Pierangeli A, Oliveto G, Sorrentino L, Di Vanna D, Pampena R, Lazzaro A, Gentilini E, Mastroianni CM, D'Ettorre G, Polimeni A, Romeo U, Villa A. Am J Otolaryngol. 2022 Nov-Dec;43(6):103549. doi: 10.1016/j.amjoto.2022.103549. Epub 2022 Jul 28. PMID: 35988522; PMCID: PMC9328839.
The non-functional ACE2 isoform, but not the SARS-CoV-2 receptor, is induced as an interferon-stimulated gene, in SARS-CoV-2 infected adults. Oliveto G, Scagnolari C, Frasca F, Sorrentino L, Matera L, Nenna R, Viscido A, Scordio M, Petrarca L, Maria Zicari A, Gentilini E, D'Ettorre G, Ceccarelli G, Midulla F, Antonelli G, Pierangeli A. Cytokine. 2022 Oct;158:155997. doi: 10.1016/j.cyto.2022.155997. Epub 2022 Aug 11. PMID: 35969900; PMCID: PMC9365862.
Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω.
Pierangeli A, Gentile M, Oliveto G, Frasca F, Sorrentino L, Matera L, Nenna R, Viscido A, Fracella M, Petrarca L, D'Ettorre G, Ceccarelli G, Midulla F, Antonelli G, Scagnolari C.
Front Immunol. 2022 Jul 12;13:873232. doi: 10.3389/fimmu.2022.873232. eCollection 2022
Post-Traumatic Stress Disorder Trajectories the Year after COVID-19 Hospitalization. Serra R, Borrazzo C, Vassalini P, Di Nicolantonio C, Koukopoulos AE, Tosato C, Cherubini F, Alessandri F, Ceccarelli G, Mastroianni CM, D'Ettorre G, Tarsitani L. Int J Environ Res Public Health. 2022 Jul 11;19(14):8452. doi: 10.3390/ijerph19148452. PMID: 35886306; PMCID: PMC9316829.
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone.
Russo A, Davoli C, Borrazzo C, Olivadese V, Ceccarelli G, Fusco P, Lazzaro A, Lionello R, Ricchio M, Serapide F, Tassone B, Gentilini Cacciola E, Mastroianni CM, Torti C, d'Ettorre G, Trecarichi EM.
Biomedicines. 2022 Jun 29;10(7):1548. doi: 10.3390/biomedicines10071548
High frequency of neutralizing antibodies to type I Interferon in HIV-1 patients hospitalized for COVID-19. Scordio M, Frasca F, Santinelli L, Sorrentino L, Pierangeli A, Turriziani O, Mastroianni CM, Antonelli G, Viscidi RP, d'Ettorre G, Scagnolari C.
Clin Immunol. 2022 Jun 25;241:109068. doi: 10.1016/j.clim.2022
Providing a simple and easily accessible diagnostic tool for HIV diagnosis does not always match success in screening campaigns addressed to migrant populations. Giancarlo Ceccarelli, Silvia Angeletti, Serena Vita, Antonio Crialesi, Marco Ciotti , Ornella Spagnolello, Laura Elena Pacifici , Sivia Fabris, Massimo Ciccozzi, Gabriella d'Ettorre
Int J Infect Dis. 2022 Jun 16;122:373-374. doi: 10.1016/j.ijid.2022.06.015
Non-B subtypes account for a large proportion of clustered primary HIV-1 infections in Italy.
Bozzi G, Fabeni L, Abbate I, Berno G, Muscatello A, Taramasso L, Fabbiani M, Nozza S, Tambussi G, Rusconi S, Giacomelli A, Focà E, Pinnetti C, d'Ettorre G, Mussini C, Borghi V, Celesia BM, Madeddu G, Di Biagio A, Ripamonti D, Squillace N, Antinori A, Gori A, Capobianchi MR, Bandera A; INACTION study group.
Sex Transm Infect. 2022 Apr 20 : sextrans-2021-055289. doi: 10.1136/sextrans-2021-055289
Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report
Di Palma M, Gentilini E, Masucci C, Micozzi A, Turriziani O, Mulè A, Foà R, Martelli M, D'Ettorre G, Capria S, Chiaretti S.
Mediterr J Hematol Infect Dis. 2022 May 1;14(1):e2022043. doi: 10.4084/MJHID.2022.043. eCollection 2022
Anti-IFN-α/-ω neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity.
Frasca F, Scordio M, Santinelli L, Gabriele L, Gandini O, Criniti A, Pierangeli A, Angeloni A, Mastroianni CM, d'Ettorre G, Viscidi RP, Antonelli G, Scagnolari C.
Eur J Immunol. 2022 Apr 13:10.1002/eji.202249824. doi: 10.1002/eji.202249824.

Covid-19 sequelae in working age patients: A systematic review. d'Ettorre G, Gentilini Cacciola E, Santinelli L, De Girolamo G, Spagnolello O, Russo A, Tarsitani L, Ciccozzi M, Mastroianni CM, d'Ettorre G, Ceccarelli G. J Med Virol. 2022 Mar;94(3):858-868. doi: 10.1002/jmv.27399. Epub 2021 Oct 22. PMID: 34655247; PMCID: PMC8661973.

Analysis of serum microRNAs and rs2910164 GC single-nucleotide polymorphism of miRNA-146a in COVID-19 patients.
Pinacchio C, Scordio M, Santinelli L, Frasca F, Sorrentino L, Bitossi C, Oliveto G, Viscido A, Ceci FM, Celani L, Ceccarelli G, Antonelli G, Mastroianni CM, d'Ettorre G, Scagnolari C.
J Immunoassay Immunochem. 2022 Feb 28:1-18. doi: 10.1080/15321819.2022.2035394. Online ahead of print.
PMID: 35227165

HPV Vaccination after Primary Treatment of HPV-Related Disease across Different Organ Sites: A Multidisciplinary Comprehensive Review and Meta-Analysis.
Di Donato V, Caruso G, Bogani G, Cavallari EN, Palaia G, Perniola G, Ralli M, Sorrenti S, Romeo U, Pernazza A, Pierangeli A, Clementi I, Mingoli A, Cassoni A, Tanzi F, Cuccu I, Recine N, Mancino P, de Vincentiis M, Valentini V, d'Ettorre G, Della Rocca C, Mastroianni CM, Antonelli G, Polimeni A, Muzii L, Palaia I.
Vaccines (Basel). 2022 Feb 4;10(2):239. doi: 10.3390/vaccines10020239.
PMID: 35214697 Free PMC article. Review.

Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19.
Sorrentino L, Silvestri V, Oliveto G, Scordio M, Frasca F, Fracella M, Bitossi C, D'Auria A, Santinelli L, Gabriele L, Pierangeli A, Mastroianni CM, d'Ettorre G, Antonelli G, Caruz A, Ottini L, Scagnolari C.
Microorganisms. 2022 Feb 4;10(2):363. doi: 10.3390/microorganisms10020363.
PMID: 35208821 Free PMC article.

CURB-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with SARS-CoV-2 pneumonia.
Oliva A, Borrazzo C, Mascellino MT, Curtolo A, Al Ismail D, Cancelli F, Galardo G, Bucci T, Ceccarelli G, d'Ettorre G, Pugliese F, Mastroianni CM, Venditti M.
Infez Med. 2021 Sep 10;29(3):408-415. doi: 10.53854/liim-2903-12. eCollection 2021.
PMID: 35146346 Free PMC article.

Human genital tracts microbiota: dysbiosis crucial for infertility.
Venneri MA, Franceschini E, Sciarra F, Rosato E, D'Ettorre G, Lenzi A.
J Endocrinol Invest. 2022 Feb 3. doi: 10.1007/s40618-022-01752-3. Online ahead of print.
PMID: 35113404 Review.
Parietal intrahemispheric source connectivity of resting-state electroencephalographic alpha rhythms is abnormal in Naïve HIV patients.
Babiloni C, Del Percio C, Lizio R, Lopez S, Pennica A, Roma P, Correr V, Cucciolla F, Toma G, Soricelli A, Di Campli F, Aceti A, Teti E, Sarmati L, Crocetti G, Ferri R, Lorenzo I, Galli M, Negri C, Angarano G, Saracino A, Lepore L, Di Pietro M, Fusco FM, Vullo V, D'Ettorre G, Pagliano P, Di Flumeri G, Celesia BM, Gentilini Cacciola E, Di Perri G, Calcagno A, Stocchi F, Ferracuti S, Onorati P, Andreoni M, Noce G.
Brain Res Bull. 2022 Apr;181:129-143. doi: 10.1016/j.brainresbull.2022.01.015. Epub 2022 Jan 29.PMID: 35101575

Oral Bacteriotherapy Reduces the Occurrence of Chronic Fatigue in COVID-19 Patients.
Santinelli L, Laghi L, Innocenti GP, Pinacchio C, Vassalini P, Celani L, Lazzaro A, Borrazzo C, Marazzato M, Tarsitani L, Koukopoulos AE, Mastroianni CM, d'Ettorre G, Ceccarelli G.
Front Nutr. 2022 Jan 12;8:756177. doi: 10.3389/fnut.2021.756177. eCollection 2021.
PMID: 35096923 Free PMC article.

Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort.
Ciccullo A, Baldin G, Borghi V, Lagi F, Latini A, d'Ettorre G, Oreni L, Fusco P, Capetti A, Fabbiani M, Giacomelli A, Grimaldi A, Madeddu G, Sterrantino G, Mussini C, Di Giambenedetto S.
Viruses. 2022 Jan 17;14(1):163. doi: 10.3390/v14010163.
PMID: 35062367 Free PMC article.

The Interplay between Host Defense, Infection, and Clinical Status in Septic Patients: A Narrative Review.
Lazzaro A, De Girolamo G, Filippi V, Innocenti GP, Santinelli L, Ceccarelli G, Trecarichi EM, Torti C, Mastroianni CM, d'Ettorre G, Russo A.
Int J Mol Sci. 2022 Jan 12;23(2):803. doi: 10.3390/ijms23020803.
PMID: 35054993 Free PMC article. Review.
Switching to a Bictegravir Single Tablet Regimen in Elderly People Living with HIV-1: Data Analysis from the BICTEL Cohort.
Lazzaro A, Cacciola EG, Borrazzo C, Innocenti GP, Cavallari EN, Mezzaroma I, Falciano M, Fimiani C, Mastroianni CM, Ceccarelli G, d'Ettorre G.
Diagnostics (Basel). 2021 Dec 29;12(1):76. doi: 10.3390/diagnostics12010076.
PMID: 35054243 Free PMC article.
SARS-CoV-2 Among Migrants Recently Arrived in Europe From Low- and Middle-Income Countries: Containment Strategies and Special Features of Management in Reception Centers.
Fabris S, d'Ettorre G, Spagnolello O, Russo A, Lopalco M, D'Agostino F, Vassalini P, Celani L, Aronica R, Gabrielli S, d'Ettorre G, Angeletti S, Mastroianni CM, Ciccozzi M, Ceccarelli G.
Front Public Health. 2021 Nov 30;9:735601. doi: 10.3389/fpubh.2021.735601. eCollection 2021.
Alzheimer Dementia in People Living With HIV.
Calcagno A, Celani L, Trunfio M, Orofino G, Imperiale D, Atzori C, Arena V, d'Ettorre G, Guaraldi G, Gisslen M, Di Perri G.
Neurol Clin Pract. 2021 Oct;11(5):e627-e633. doi: 10.1212/CPJ.0000000000001060.
Human Immunodeficiency Virus Type 2: The Neglected Threat.
Ceccarelli G, Giovanetti M, Sagnelli C, Ciccozzi A, d'Ettorre G, Angeletti S, Borsetti A, Ciccozzi M.
Pathogens. 2021 Oct 25;10(11):1377. doi: 10.3390/pathogens10111377.
Clinical Effects of Oral Bacteriotherapy on Anal HPV Infection and Related Dysplasia in HIV-Positive MSM: Results from the "HPVinHIV" Trial.
Cavallari EN, Ceccarelli G, Santinelli L, Innocenti GP, De Girolamo G, Borrazzo C, Spagnolello O, Scagnolari C, Arcieri S, Ciardi A, Pierangeli A, Mastroianni CM, d'Ettorre G.
Biomedicines. 2021 Nov 22;9(11):1738. doi: 10.3390/biomedicines9111738
Comparison of Thrombotic Events and Mortality in Patients with Community-Acquired Pneumonia and COVID-19: A Multicenter Observational Study.
Cangemi R, Calvieri C, Falcone M, Cipollone F, Ceccarelli G, Pignatelli P, D'Ardes D, Pirro M, Alessandri F, Lichtner M, D'Ettorre G, Oliva A, Aronica R, Rocco M, Venditti M, Romiti GF, Tiseo G, Taliani G, Menichetti F, Pugliese F, Mastroianni CM, Violi F.
Thromb Haemost. 2021 Nov 10. doi: 10.1055/a-1692-9939.
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review.
d'Ettorre G, Ceccarelli G, Santinelli L, Vassalini P, Innocenti GP,Alessandri F, Koukopoulos AE, Russo A, d'Ettorre G, Tarsitani L.
Int J Environ Res Public Health. 2021 Jan 12;18(2):E601. doi:
10.3390/ijerph18020601. PMID: 33445712.
Differential induction of type I and III interferon genes in the upper respiratory tract of
patients with coronavirus disease 2019 (COVID-19).
Scagnolari C, Pierangeli A, Frasca F, Bitossi C, Viscido A, Oliveto G,Scordio M, Mazzuti L, Di Carlo D, Gentile M, Solimini A, Ceccarelli G, Pugliese F, Mastroianni CM, d'Ettorre G, Turriziani O, Antonelli G; Virology and Infectious Diseases COVID-19 Study Group of Sapienza University. Virus Res. 2021 Jan 5:198283. doi: 10.1016/j.virusres.2020.198283. Epub ahead of print. PMID: 33418027.
Efficacy of Remdesivir-Containing Therapy in Hospitalized COVID-19 Patients: A Prospective Clinical Experience. Russo A, Binetti E, Borrazzo C, Cacciola EG, Battistini L, Ceccarelli G, Mastroianni CM, d'Ettorre G. J Clin Med. 2021 Aug 24;10(17):3784. doi: 10.3390/jcm10173784. PMID: 34501233; PMCID: PMC8432083.
Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding. Ciccullo A, Borghi V, Giacomelli A, Cossu MV, Sterrantino G, Latini A, Giacometti A, De Vito A, Gennari W, Madeddu G, Capetti A, d'Ettorre G, Mussini C, Rusconi S, Di Giambenedetto S, Baldin G. J Acquir Immune Defic Syndr. 2021 Nov 1;88(3):234-237. doi: 10.1097/QAI.0000000000002787. PMID: 34446677.
Oxygen Sparing Effect of Bacteriotherapy in COVID-19. Ceccarelli G, Marazzato M, Celani L, Lombardi F, Piccirilli A, Mancone M, Trinchieri V, Pugliese F, Mastroianni CM, d'Ettorre G. Nutrients. 2021 Aug 23;13(8):2898. doi: 10.3390/nu13082898. PMID: 34445055; PMCID: PMC8401839.
Antiretroviral Therapy Dampens Mucosal CD4+ T Lamina Propria Lymphocytes Immune Activation in Long-Term Treated People Living with HIV-1. Lazzaro A, Innocenti GP, Santinelli L, Pinacchio C, De Girolamo G, Vassalini P, Fanello G, Mastroianni CM, Ceccarelli G, d'Ettorre G. Microorganisms. 2021 Jul 30;9(8):1624. doi: 10.3390/microorganisms9081624. PMID: 34442703; PMCID: PMC8402205.
Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up.
Maestrini V, Birtolo LI, Francone M, Galardo G, Galea N, Severino P, Alessandri F, Colaiacomo MC, Cundari G, Chimenti C, Lavalle C, Ciardi M, Palange P, Deales A, d'Ettorre G, Mastroianni CM, Catalano C, Ruberto F, Pugliese F, d'Amati G, Fedele F, Mancone M; Policlinico Umberto I COVID-19 Group. Int J Cardiol. 2021 Jul 2:S0167-5273(21)01094-9. doi: 10.1016/j.ijcard.2021.06.056
Clinical Characteristics and Outcome of Patients with Suspected COVID-19 in Emergency Department (RESILIENCY Study II). Russo A, Gentilini Cacciola E, Borrazzo C, Filippi V, Bucci T, Vullo F, Celani L, Binetti E, Battistini L, Ceccarelli G, Alessandroni M, Galardo G, Mastroianni CM, d'Ettorre G. Diagnostics (Basel). 2021 Jul 29;11(8):1368. doi: 10.3390/diagnostics11081368. PMID: 34441304; PMCID: PMC8393530.
Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19. Oliva A, Miele MC, Di Timoteo F, De Angelis M, Mauro V, Aronica R, Al Ismail D, Ceccarelli G, Pinacchio C, d'Ettorre G, Mascellino MT, Mastroianni CM. Front Immunol. 2021 Jul 14;12:708149. doi: 10.3389/fimmu.2021.708149. PMID: 34335624; PMCID: PMC8316921.
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort. Fabbiani M, Rossetti B, Ciccullo A, Oreni L, Lagi F, Celani L, Colafigli M, De Vito A, Mazzitelli M, Dusina A, Durante M, Montagnani F, Rusconi S, Capetti A, Sterrantino G, D'Ettorre G, Di Giambenedetto S; ODOACRE Study Group. HIV Med. 2021 Oct;22(9):843-853. doi: 10.1111/hiv.13146. Epub 2021 Jul 27. PMID: 34318591.
Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.
Violi F, Ceccarelli G, Cangemi R, Cipollone F, D'Ardes D, Oliva A, Pirro M, Rocco M, Alessandri F, D'Ettorre G, Lichtner M, Pignatelli P, Ferro D, Ruberto F, Lip GYH, Pugliese F, Mastroianni CM; Intensive Care, Infectious Diseases COVID-19 Study Group of Sapienza University. Intern Emerg Med. 2021 Jul 4:1-7. doi: 10.1007/s11739-020-02621-8. Online ahead of print.
KI and WU Polyomavirus in Respiratory Samples of SARS-CoV-2 Infected Patients.
Prezioso C, Moens U, Oliveto G, Brazzini G, Piacentini F, Frasca F, Viscido A, Scordio M, Guerrizio G, Rodio DM, Pierangeli A, d'Ettorre G, Turriziani O, Antonelli G, Scagnolari C, Pietropaolo V. Microorganisms. 2021 Jun 9;9(6):1259. doi: 10.3390/microorganisms9061259.
Early antibiotic treatment in emergency department: the critical balance. Russo A, Venditti M, Ceccarelli G, Mastroianni CM, d'Ettorre G. Intern Emerg Med. 2021 Jun 6. doi: 10.1007/s11739-021-02779-9. Online ahead of print.PMID: 34091840
Lesson learned from the 2017 measles outbreak in Italy: report from an emergency department. Spagnolello O, Russo A, Borrazzo C, d'Ettorre G, Ceccarelli G. Infez Med. 2021 Jun 1;29(2):252-258.PMID: 34061791
Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission. Oliva A, Ceccarelli G, Borrazzo C, Ridolfi M, D 'Ettorre G, Alessandri F, Ruberto F, Pugliese F, Raponi GM, Russo A, Falletta A, Mastroianni CM, Venditti M. Infection. 2021 May 26:1-11. doi: 10.1007/s15010-021-01624-7. Online ahead of print. PMID: 34036458
Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients.
Santinelli L, De Girolamo G, Borrazzo C, Vassalini P, Pinacchio C, Cavallari EN, Statzu M, Frasca F, Scordio M, Bitossi C, Viscido A, Ceccarelli G, Mancone M, Mastroianni CM, Antonelli G, d'Ettorre G, Scagnolari C. J Med Virol. 2021 Aug;93(8):4930-4938. doi: 10.1002/jmv.27028. Epub 2021 May 3.PMID: 33913525
The importance of genomic analysis in cracking the coronavirus pandemic.
Zella D, Giovanetti M, Cella E, Borsetti A, Ciotti M, Ceccarelli G, D'Ettorre G, Pezzuto A, Tambone V, Campanozzi L, Magheri M, Unali F, Bianchi M, Benedetti F, Pascarella S, Angeletti S, Ciccozzi M.
Expert Rev Mol Diagn. 2021 Jun;21(6):547-562. doi: 10.1080/14737159.2021.1917998. Epub 2021 Apr 28. PMID: 33849359
Viral community acquired pneumonia at the emergency department: Report from the pre COVID-19 age. Spagnolello O, Pierangeli A, Cedrone MC, Di Biagio V, Gentile M, Leonardi A, Valeriano C, Innocenti GP, Santinelli L, Borrazzo C, Russo A, Oliveto G, Viscido A, Ciccozzi M, Bertazzoni G, d'Ettorre G, Ceccarelli G. J Med Virol. 2021 Jul;93(7):4399-4404. doi: 10.1002/jmv.26980. Epub 2021 Apr 6.PMID: 33783850
Dysbiosis in SARS-CoV-2-Infected Patients. Marazzato M, Ceccarelli G, d'Ettorre G. Gastroenterology. 2021 May;160(6):2195. doi: 10.1053/j.gastro.2020.12.056. Epub 2020 Dec 30. PMID: 33387514; PMCID: PMC7773314.
Beyond Bone: Infectious Diseases and Immunity in Parathyroid Disorders.Hasenmajer V, Puliani G, Minnetti M, Sbardella E, Mastroianni CM, D'Ettorre G, Isidori AM, Gianfrilli D. Adv Exp Med Biol. 2021 Mar 30. doi: 10.1007/5584_2021_629. Online ahead of print.
PMID: 33782903
Post-traumatic Stress Disorder Among COVID-19 Survivors at 3-Month Follow-up After Hospital Discharge. Tarsitani L, Vassalini P, Koukopoulos A, Borrazzo C, Alessi F, Di Nicolantonio C, Serra R, Alessandri F, Ceccarelli G, Mastroianni CM, d'Ettorre G. J Gen Intern Med. 2021 Jun;36(6):1702-1707. doi: 10.1007/s11606-021-06731-7. Epub 2021 Mar 29. PMID: 33782888
Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection. Spagnolello O, Pinacchio C, Santinelli L, Vassalini P, Innocenti GP, De Girolamo G, Fabris S, Giovanetti M, Angeletti S, Russo A, Mastroianni CM, Ciccozzi M, Ceccarelli G, d'Ettorre G. Chemotherapy. 2021;66(1-2):24-32. doi: 10.1159/000515344. Epub 2021 Mar 23.PMID: 33756475
The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study). Ceccarelli G, Alessandri F, Oliva A, Borrazzo C, Dell'Isola S, Ialungo AM, Rastrelli E, Pelli M, Raponi G, Turriziani O, Ruberto F, Rocco M, Pugliese F, Russo A, d'Ettorre G, Venditti M. J Med Virol. 2021 Jul;93(7):4319-4325. doi: 10.1002/jmv.26925. Epub 2021 Mar 26. PMID: 33675235
Procalcitonin in daily clinical practice: an evergreen tool also during a pandemic. Russo A, Venditti M, Ceccarelli G, Mastroianni CM, d'Ettorre G.
Intern Emerg Med. 2021 Apr;16(3):541-543. doi: 10.1007/s11739-021-02659-2. Epub 2021 Feb 12.PMID: 33580413
Malaria in an asylum seeker paediatric liver transplant recipient: diagnostic challenges for migrant population. Vita S, Gabrielli S, Fontanelli Sulekova L, De Angelis M, Alessandri F, Pugliese F, Ruberto F, Spagnolello O, Mazzocato V, Celani L, Lopalco M, Mattiucci S, Bazzardi R, Angeletti S, Ciccozzi M, D'Ettorre G, Ceccarelli G.
J Infect Dev Countries. 2021 Jan 31;15(1):172-178. doi: 10.3855/jidc.12541.PMID: 33571161
First report of spondylodiscitis caused by Bacillus circulans in an immunocompetent patient: Clinical case and review of the literature.
Russo A, Tarantino U, d'Ettorre G, Della Rocca C, Ceccarelli G, Gasbarra E, Venditti M, Iundusi R.
IDCases. 2021 Jan 26;23:e01058. doi: 10.1016/j.idcr.2021.e01058. eCollection 2021.
PMID: 33552902
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study.Ceccarelli G, Borrazzo C, Pinacchio C, Santinelli L, Innocenti GP, Cavallari EN, Celani L, Marazzato M, Alessandri F, Ruberto F, Pugliese F, Venditti M, Mastroianni CM, d'Ettorre G.
Front Nutr. 2021 Jan 11;7:613928. doi: 10.3389/fnut.2020.613928. eCollection 2020.
Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV: 48-Week Results in Real-Life Setting. Di Carlo D, Falasca F, Palermo E, Mezzaroma I, Fimiani C, Siccardi G, Celani L, Di Campli FM, d'Ettorre G, Antonelli G, Turriziani O. AIDS Res Hum Retroviruses. 2021 Jun;37(6):478-485. doi: 10.1089/AID.2020.0196. Epub 2021 Mar 1.PMID: 33487130
SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients.
Bitossi C, Frasca F, Viscido A, Oliveto G, Scordio M, Belloni L, Cimino G, Pietropaolo V, Gentile M, d'Ettorre G, Midulla F, Trancassini M, Antonelli G, Pierangeli A, Scagnolari C.
Microorganisms. 2021 Jan
3;9(1):E93. doi: 10.3390/microorganisms9010093. PMID: 33401565.
Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report.
Violi F, Ceccarelli G, Loffredo L, Alessandri F, Cipollone F, D'ardes D,
D'Ettorre G, Pignatelli P, Venditti M, Mastroianni CM, Pugliese F.
Thromb Haemost. 2020 Dec 23. doi: 10.1055/s-0040-1721486. Epub ahead of print.
PMID: 33368057.
Efficacy of Daptomycin-Containing Regimen for Treatment of Staphylococcal or Enterococcal VertebralOsteomyelitis: A Prospective Clinical Experience. Antibiotics (Basel). Russo A, Ceccarelli G, Bellelli V, Bianchi L, Marincola Cattaneo F, Gregori F, Palmarini V, Marotta N, Landi A, Cuzzolino A, Stefanini M, Aureli A, Mastroianni CM, Venditti M, d'Ettorre G, Sabetta F. Antibiotics 2020 Dec 10;9(12):889. doi: 10.3390/antibiotics9120889. PMID: 33321967; PMCID:PMC7764531.
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization. Curtolo A, Oliva A, Volpicelli L, Ceccarelli G, D'Ettorre G, Borrazzo C, Mastroianni CM, Venditti M.
Infez Med. 2020 Dec 1;28(4):534-538. PMID: 33257627.
The Role of Targeted HIV Screening in the Emergency Department: A Scoping Review.
Spagnolello O, Gallagher B, Lone N, Ceccarelli G, D'Ettorre G, Reed MJ.
Curr HIV Res. 2020 Nov 22. doi: 10.2174/1570162X18666201123113905. Epub ahead of
print. PMID: 33231157.
Comparison between hospitalized patients affected or not by COVID-19 (RESILIENCY
study). Russo A, Bellelli V, Ceccarelli G, Marincola Cattaneo F, Bianchi L, Pierro R,
Russo R, Steffanina A, Pugliese F, Mastroianni CM, d'Ettorre G, Sabetta F.
Clin Infect Dis. 2020 Nov 18:ciaa1745. doi: 10.1093/cid/ciaa1745. Epub
ahead of print. PMID: 33206938; PMCID: PMC7717191.
Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of
probiozovid trial. Araimo F, Imperiale C, Tordiglione P, Ceccarelli G, Borrazzo C, Alessandri
F, Santinelli L, Innocenti GP, Pinacchio C, Mauro V, Recchia GE, Zancla S, Calò
A, Poscia R, Ruberto F, d'Ettorre G, Bilotta F, Mastroianni C, Pugliese F.
J Med Virol. 2020 Oct 28. doi: 10.1002/jmv.26636. Epub ahead
of print. PMID: 33111980.
Retinal involvement and ocular findings in COVID-19 pneumonia patients. Pirraglia MP, Ceccarelli G, Cerini A, Visioli G, d'Ettorre G, Mastroianni CM, Pugliese F, Lambiase A, Gharbiya M. Sci Rep. 2020 Oct 15;10(1):17419. doi:
10.1038/s41598-020-74446-6. PMID: 33060700; PMCID: PMC7566835.
Procalcitonin in the Assessment of Ventilator Associated Pneumonia: A Systematic Review. Alessandri F, Pugliese F, Angeletti S, Ciccozzi M, Russo A, Mastroianni CM,
d'Ettorre G, Venditti M, Ceccarelli G.
Adv Exp Med Biol. 2020 Oct
9. doi: 10.1007/5584_2020_591. Epub ahead of print. PMID: 33030706.
qSOFA as a new community-acquired pneumonia severity score in the emergency setting. Spagnolello O, Ceccarelli G, Borrazzo C, Macrì A, Suppa M, Baldini E,
Garramone A, Alessandri F, Celani L, Vullo F, Angeletti S, Ciccozzi M,
Mastroianni C, Bertazzoni G, D'Ettorre G.
Emerg Med J. 2020 Oct 6: emermed-2019-208789. doi: 10.1136/emermed-2019-208789. Epub ahead of print.
PMID: 33023921.
Overall Tolerability of Integrase Inhibitors in Clinical Practice: Results from a Multicenter Italian Cohort.Ciccullo A, Baldin G, Borghi V, Sterrantino G, Madeddu G, Latini A, d'Ettorre G, Lanari A, Mazzitelli M, Colafigli M, Capetti AF, Oreni L, Lagi F, Rusconi S, Di Giambenedetto S. AIDS Res Hum Retroviruses. 2021 Jan;37(1):4-10. doi: 10.1089/AID.2020.0078. Epub 2020 Nov 2.
PMID: 32998526.
Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. Ceccarelli G, Alessandri F, Oliva A, Dell'Isola S, Rocco M, Ruberto F,
Pugliese F, d'Ettorre G, Venditti M.
Eur J Clin Invest. 2021 Jan;51(1):e13418.
doi: 10.1111/eci.13418. Epub 2020 Oct 14. PMID: 32997792; PMCID: PMC7536912.
Preliminary Attempt to Predict Risk of Invasive Pulmonary Aspergillosis in
Patients with Influenza: Decision Trees May Help?
Bellelli V, Siccardi G, Conte L, Celani L, Congeduti E, Borrazzo C, Santinelli L, Innocenti GP, Pinacchio C, Ceccarelli G, Venditti M, d'Ettorre G.
Antibiotics (Basel). 2020 Sep
26;9(10):644. doi: 10.3390/antibiotics9100644. PMID: 32993060; PMCID:
PMC7600971.
Surveillance of COVID-19 in migrant reception centers: a call for action. Ceccarelli G, Lopalco M, d'Ettorre G, d'Ettorre G, Ciccozzi M.
J Travel Med. 2020
Sep 18:taaa171. doi: 10.1093/jtm/taaa171. Epub ahead of print. PMID: 32946580;
PMCID: PMC7543393.
Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report. d'Ettorre G, Recchia G, Ridolfi M, Siccardi G, Pinacchio C, Innocenti GP,
Santinelli L, Frasca F, Bitossi C, Ceccarelli G, Borrazzo C, Antonelli G,
Scagnolari C, Mastroianni CM.
Medicine (Baltimore). 2020 Sep 4;99(36):e21803. doi: 10.1097/MD.0000000000021803.
Preventing influenza and influenza like illness during Covid-19 pandemic: A call for
action. d'Ettorre G, Ceccarelli G, Pinacchio C, Ciccozzi M, d'Ettorre G.
Early Hum Dev. 2020 Aug 12:105156. doi:
10.1016/j.earlhumdev.2020.105156. Epub ahead of print. PMID: 32819796; PMCID:
PMC7422819.
Is previous influenza-like illness a potential Trojan horse for
COVID-19?
Ceccarelli G, d'Ettorre G, Innocenti GP, Mastroianni CM, Ciccozzi M,
d'Ettorre G.
Crit Care. 2020 Aug 14;24(1):503. doi: 10.1186/s13054-020-03226-5.
PMID: 32799917; PMCID: PMC7427759.
Nox2 activation in Covid-19.Violi F, Oliva A, Cangemi R, Ceccarelli G, Pignatelli P, Carnevale R, Cammisotto V, Lichtner M, Alessandri F, De Angelis M, Miele MC, D'Ettorre G,
Ruberto F, Venditti M, Pugliese F, Mastroianni CM.
Redox Biol. 2020 Sep;36:101655. doi: 10.1016/j.redox.2020.101655. Epub 2020 Jul
PMID: 32738789; PMCID: PMC7381406.
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19. d'Ettorre G, Ceccarelli G, Marazzato M, Campagna G, Pinacchio C, Alessandri
F, Ruberto F, Rossi G, Celani L, Scagnolari C, Mastropietro C, Trinchieri V,
Recchia GE, Mauro V, Antonelli G, Pugliese F, Mastroianni CM.
Front in Med (Lausanne). 2020 Jul 7;7:389. doi: 10.3389/fmed.2020.00389. PMID: 32733907;
PMCID: PMC7358304.
High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients.
Pinacchio C, Scagnolari C, Iebba V, Santinelli L, Innocenti GP, Frasca F,
Bitossi C, Scordio M, Oliveto G, Ceccarelli G, Antonelli G, Mastroianni CM,
d'Ettorre G.
AIDS. 2020 Aug 1;34(10):1467-1473. doi: 10.1097/QAD.0000000000002574. PMID: 32675560.
Probiotics and COVID-19. Ceccarelli G, Scagnolari C, Pugliese F, Mastroianni CM, d'Ettorre G.
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):721-722.
doi: 10.1016/S2468-1253(20)30196-5. PMID: 32673604; PMCID: PMC7357989.
Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial.
Innocenti GP, Santinelli L, Laghi L, Borrazzo C, Pinacchio C, Fratino M,
Celani L, Cavallari EN, Scagnolari C, Frasca F, Antonelli G, Mastroianni CM,
d'Ettorre G, Ceccarelli G.
Metabolites. 2020 Jul 3;10(7):274. doi: 10.3390/metabo10070274.
PMID: 32635406; PMCID: PMC7408387.
INACTION study group. Predictors of incomplete viral response and virologic
failure in patients with acute and early HIV infection. Results of Italian
Network of ACuTe HIV InfectiON (INACTION) cohort. Taramasso L, Fabbiani M, Nozza S, De Benedetto I, Bruzzesi E, Mastrangelo A, Pinnetti C, Calcagno A, Ferrara M, Bozzi G, Focà E, Quiros-Roldan E, Ripamonti D, Campus M, Celesia BM, Torti C, Cosco L, Di Biagio A, Rusconi S, Marchetti G, Mussini C, Gulminetti R, Cingolani A, d'Ettorre G, Madeddu G, Franco A, Orofino G, Squillace N, Muscatello A, Gori A, Antinori A, Tambussi G, Bandera A;
HIV Med. 2020 Sep;21(8):523-535. doi: 10.1111/hiv.12885. Epub 2020 Jun 24. PMID: 32578947.
Targeting the NO-cGMP-PDE5 pathway in COVID-19 infection. The DEDALO project.
Isidori AM, Giannetta E, Pofi R, Venneri MA, Gianfrilli D, Campolo F,
Mastroianni CM, Lenzi A, d'Ettorre G.
Andrology. 2020 Jun
11:10.1111/andr.12837. doi: 10.1111/andr.12837. Epub ahead of print. PMID:
32526061; PMCID: PMC7307129
Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2
Infection: A Scoping Review. Infusino F, Marazzato M, Mancone M, Fedele F, Mastroianni CM, Severino P, Ceccarelli G, Santinelli L, Cavarretta E, Marullo AGM, Miraldi F, Carnevale R,
Nocella C, Biondi-Zoccai G, Pagnini C, Schiavon S, Pugliese F, Frati G,
d'Ettorre G.
Nutrients. 2020 Jun 8;12(6):1718. doi:
10.3390/nu12061718. PMID: 32521760; PMCID: PMC7352781.
Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19.Violi F, Ceccarelli G, Cangemi R, Alessandri F, D'Ettorre G, Oliva A, Pastori D, Loffredo L, Pignatelli P, Ruberto F, Venditti M, Pugliese F, Mastroianni CM.
Circ Res. 2020 Jul 17;127(3):400-401. doi: 10.1161/CIRCRESAHA.120.317173. Epub
2020 Jun 8. PMID: 32508261.
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients. Antonelli G, Turriziani O, Pierangeli A, d'Ettorre G, Galardo G, Pugliese F,
Mastroianni CM, Scagnolari C.
J Clin Virol. 2020 Jul;128:104450. doi:
10.1016/j.jcv.2020.104450. Epub 2020 May 20. PMID: 32464309; PMCID: PMC7237947.
Is teicoplanin a complementary treatment option for COVID-19? The question remains. Ceccarelli G, Alessandri F, d'Ettorre G, Borrazzo C, Spagnolello O, Oliva A,
Ruberto F, Mastroianni CM, Pugliese F, Venditti M; Intensive Care COVID-19 Study
Group of Sapienza University.
Int J Antimicrob Agents. 2020
Aug;56(2):106029. doi: 10.1016/j.ijantimicag.2020.106029. Epub 2020 May 23.
PMID: 32454071; PMCID: PMC7245324.
Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients.
Santinelli L, Ceccarelli G, Borrazzo C, Innocenti GP, Frasca F, Cavallari
EN, Celani L, Nonne C, Mastroianni CM, d'Ettorre G. Biol Sex Differ. 2020 May 1;11(1):23. doi: 10.1186/s13293-020-00302-x. PMID:
32357901; PMCID: PMC7195770.
Inaction Study Group. Enhanced Immunological Recovery With Early Start of
Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian
Network of ACuTe HIV InfectiON (INACTION) Retrospective Study. Muscatello A, Nozza S, Fabbiani M, De Benedetto I, Ripa M, Dell'acqua R, Antinori A, Pinnetti C, Calcagno A, Ferrara M, Focà E, Quiros-Roldan E, Ripamonti D, Campus M, Maurizio Celesia B, Torti C, Cosco L, Di Biagio A, Rusconi S, Marchetti G, Mussini C, Gulminetti R, Cingolani A, D'ettorre G,
Madeddu G, Franco A, Orofino G, Squillace N, Gori A, Tambussi G, Bandera A;
Pathog Immun.
2020 Feb 24;5(1):8-33. doi: 10.20411/pai.v5i1.341. PMID: 32258852; PMCID:
PMC7104556.
Antibacterial Effectiveness of Fecal Water and in Vitro Activity of a Multi-Strain Probiotic Formulation against Multi-Drug resistant Microorganisms. Oliva A, Miele MC, De Angelis M, Costantini S, Mascellino MT, Mastroianni CM, Vullo V, d'Ettorre G.
Microorganisms. 2020 Feb 27;8(3):332. doi:
10.3390/microorganisms8030332. PMID: 32120875; PMCID: PMC7143114.
Real word outcomes associated with use of raltegravir in older
people living with HIV: results from the 60 months follow-up of the RAL-age
cohort. Santinelli L, Ceccarelli G, Borrazzo C, Celani L, Pavone P, Innocenti GP,
Spagnolello O, Fimiani C, Ceci F, Di Sora F, Mezzaroma I, Mastroianni CM,
d'Ettorre G.
Expert Rev Anti Infect Ther. 2020 May;18(5):485-492. doi:
10.1080/14787210.2020.1733415. Epub 2020 Feb 25. PMID: 32096433.
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection. Vita S, Zuccalà P, Savinelli S, Mascia C, Rossi R, Schiavone F, Marocco R, Tieghi T, Iannetta M, Nijhawan P, Zingaropoli MA, d'Ettore G, Vullo V, Mastroianni CM, Lichtner M. J Immunol Res. 2020 Mar 16;2020:2781350. doi: 10.1155/2020/2781350. PMID: 32258171; PMCID: PMC7102477.
High HIV-1 diversity in immigrants resident in Italy (2008-2017).Maggiorella MT, Sanarico N, Brindicci G, Monno L, Santoro CR, Coppola N, Cuomo N, Azzurri A, Cesario F, Luciani F, El-Hamad I, D'Ettorre G, Turriziani O,Mazzuti L, Poggi A, Vichi F, Mariabelli E, Surace L, Berardelli G, Picconi O,Cenci A, Sernicola L, Rovetto C, Fulgenzi D, Belli R, Salvi E, Zeo PD, Borsetti A, Ridolfi B, Losappio R, Zoboli F, Schietroma I, Cella E, Angeletti S, Ciccozzi
M, D'Amato S, Ensoli B, Buttò S; Italian Network for HIV Characterization.
Sci Rep. 2020 Feb 24;10(1):3226. doi: 10.1038/s41598-020-59084-2. PMID: 32094387; PMCID:
PMC7039940.
JCPyV NCCR analysis in PML patients with different risk factors:
exploring common rearrangements as essential changes for neuropathogenesis.
Ciardi MR, Zingaropoli MA, Iannetta M, Prezioso C, Perri V, Pasculli P,
Lichtner M, d'Ettorre G, Altieri M, Conte A, Pietropaolo V, Mastroianni CM,
Vullo V.
Virol J. 2020 Feb 11;17(1):23. doi: 10.1186/s12985-020-1295-5. PMID: 32046748;
PMCID: PMC7014659.
Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation. Montrucchio C, De Nicolò A, D'Ettorre G, D'Ascenzo F, Lazzaro A, Tettoni M, D'Avolio A, Bonora S, Celani L, Di Perri G, Calcagno A.
Int J Antimicrob Agents. 2020 Apr;55(4):105908. doi:
10.1016/j.ijantimicag.2020.105908. Epub 2020 Jan 25. PMID: 31991223.
Infected chronic ischemic wound topically treated with a multi-
strain probiotic formulation: a novel tailored treatment strategy. Venosi S, Ceccarelli G, de Angelis M, Laghi L, Bianchi L, Martinelli O, Maruca D, Cavallari EN, Toscanella F, Vassalini P, Trinchieri V, Oliva A, d'Ettorre G.
J Transl Med.2019 Nov 9;17(1):364. doi: 10.1186/s12967-019-2111-0. PMID: 31706326; PMCID: PMC6842486.
Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV
patients. Landi C, Santinelli L, Bianchi L, Shaba E, Ceccarelli G, Cavallari EN,
Borrazzo C, Pinacchio C, Scagnolari C, Vullo V, Bini L, d'Ettorre G.
J Neurovirol. 2020 Feb;26(1):95-106. doi: 10.1007/s13365-019-00801-7.
Epub 2019 Nov 1. PMID: 31677067.
Clinical significance of lymphocytopenia in patients hospitalized with pneumonia
caused by influenza virus. Bellelli V, d'Ettorre G, Celani L, Borrazzo C, Ceccarelli G, Venditti M.Crit Care. 2019 Oct 29;23(1):330. doi:
10.1186/s13054-019-2608-1. PMID: 31665060; PMCID: PMC6819578.
Carotid Artery Aneurysm in HIV: A Review of Case Reports in Literature. Silvestri V, Borrazzo C, Mele R, d'Ettorre G. Ann Vasc Surg. 2020 Feb;63:409-426.
doi: 10.1016/j.avsg.2019.09.012. Epub 2019 Oct 17. PMID: 31629845.
Diagnostic Issues of Asymptomatic Neurosyphilis in HIV-Positive Patients: A Retrospective Study.Ceccarelli G, Borrazzo C, Lazzaro A, Innocenti GP, Celani L, Cavallari EN,
Pinacchio C, Santinelli L, Mastroianni CM, d'Ettorre G.
Brain Sci. 2019 Oct 17;9(10):278. doi: 10.3390/brainsci9100278. PMID: 31627294;
PMCID: PMC6826495.
Assessment of Biventricular Function by Three-Dimensional Speckle Tracking
Echocardiography in Adolescents and Young Adults with Human Immunodeficiency
Virus Infection: A Pilot Study. Capotosto L, D'Ettorre G, Ajassa C, Cavallari N, Ciardi MR, Placanica G,Ricci S, Lucchetti P, Tanzilli G, Mangieri E, Gaudio C, Vullo V, Vitarelli A.
Cardiology. 2019;144(3-4):101-111. doi:
10.1159/000503140. Epub 2019 Oct 15. PMID: 31614346.
Fecal Microbial Transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent Clostridium difficile infection patients. Bruno G, Gagliardi A, Oliva A, Trancassini M, Macone A, Cicerone C, D'Abramo A, Iebba V, Auria S, Bonfiglio G, Zingaropoli MA, D'Ettorre G, Badiali D, Vullo
V, Corazziari ES, Schippa S. New Microbiol. 2019 Oct;42(4):221-224. Epub 2019 Oct 14. PMID: 31609455.
A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV- positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study). Mussini C, Roncaglia E, Borghi V, Rusconi S, Nozza S, Cattelan AM, Segala D,
Bonfanti P, Di Biagio A, Barchi E, Focà E, Degli Antoni A, Bonora S, Francisci
D, Limonta S, Antinori A, D'Ettorre G, Maggiolo F.
PLoS One.2019 Sep 27;14(9):e0222650. doi: 10.1371/journal.pone.0222650. PMID: 31560700;
PMCID: PMC6764686.
Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients. Baldin G, Ciccullo A, Rusconi S, Capetti A, Sterrantino G, Colafigli M,
d'Ettorre G, Giacometti A, Cossu MV, Borghetti A, Gennari W, Mussini C, Borghi
V, Di Giambenedetto S. Int J Antimicrob Agents. 2019
Dec;54(6):728-734. doi: 10.1016/j.ijantimicag.2019.09.002. Epub 2019 Sep 12.
PMID: 31521809.
Transmitted drug resistance mutations and trends of HIV-1
subtypes in treatment-naïve patients: A single-centre experience. Mazzuti L, Melengu T, Falasca F, Calabretto M, Cella E, Ciccozzi M, Mezzaroma I, Iaiani G, Spaziante M, d'Ettorre G, Fimiani C, Vullo V, Antonelli G, Turriziani O.
J Glob Antimicrob Resist. 2020 Mar;20:298-303. doi: 10.1016/j.jgar.2019.08.024. Epub
2019 Sep 10. PMID: 31518723.
Antiviral Activity of Fecal Water Samples from HIV-1 Infected Subjects Treated with a Specific Probiotic Formulation.Falasca F, Cavallari EN, Innocenti GP, Scagnolari C, Mezzaroma I, Santinelli L, Ceccarelli G, Vullo V, Turriziani O, d'Ettorre G.
Curr HIV Res. 2019;17(3):183-189. doi:
10.2174/1570162X17666190903230622. PMID: 31490760.
Impact of the 2017 measles outbreak on the emergency care system of a large tertiary-care
teaching hospital in Italy: a retrospective analysis. Ceccarelli G, Spagnolello O, Borrazzo C, Vullo F, Cuomo MR, Milocco M, Angeletti S, Ciccozzi M, Mastroianni CM, d'Ettorre G, Bertazzoni G.
Eur J Public Health. 2019Oct 1;29(5):966-971. doi: 10.1093/eurpub/ckz056. PMID: 31329846.
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study. Rossetti B, Baldin G, Sterrantino G, Rusconi S, De Vito A, Giacometti A, Gagliardini R, Colafigli M, Capetti A, d'Ettorre G, Celani L, Lagi F, Ciccullo
A, De Luca A, Di Giambenedetto S, Madeddu G.
Antiviral Res. 2019 Sep;169:104552. doi:
10.1016/j.antiviral.2019.104552. Epub 2019 Jul 5. PMID: 31283942.
Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS.
Ceccarelli G, Statzu M, Santinelli L, Pinacchio C, Bitossi C, Cavallari EN,
Vullo V, Scagnolari C, d'Ettorre G. Expert Opin Biol Ther. 2019 Sep;19(9):949-965. doi:
10.1080/14712598.2019.1638907. Epub 2019 Jul 10. PMID: 31260331.
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection.Giacomelli A, Fabbiani M, De Benedetto I, Nozza S, Focà E, Celesia BM,
Marchetti G, Mussini C, Antinori A, d'Ettorre G, Madeddu G, Bandera A,
Muscatello A, Rusconi S. J Med Virol. 2019 Oct;91(10):1891-1895.
doi: 10.1002/jmv.25517. Epub 2019 Jun 27. PMID: 31199538.
Short-Term Probiotic Administration Increases Fecal-Anti Candida Activity in Healthy
Subjects. De Angelis M, Scagnolari C, Oliva A, Cavallari EN, Celani L, Santinelli L,
Innocenti GP, Borrazzo C, Ceccarelli G, Vullo V, d'Ettorre G.
Microorganisms. 2019 Jun 3;7(6):162. doi:10.3390/microorganisms7060162. PMID: 31163660; PMCID: PMC6616593.
Many Different Patterns under a Common Flag: Aortic Pathology in HIV-A Review of Case Reports in Literature. Silvestri V, D'Ettorre G, Borrazzo C, Mele R.
Ann Vasc Surg. 2019 Aug;59:268-284. doi: 10.1016/j.avsg.2019.01.016. Epub 2019
Apr 30. PMID: 31051229.
Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use. Maggi P, De Socio GV, Cicalini S, D'Abbraccio M, Dettorre G, Di Biagio A, Martinelli C, Nunnari G, Rusconi S, Sighinolfi L, Spagnuolo V, Squillace N. AIDS Res Ther. 2019 May 24;16(1):11. doi: 10.1186/s12981-019-0226-2. PMID: 31126301; PMCID: PMC6534832

Physical Activity and HIV: Effects on Fitness Status, Metabolism, Inflammation and
Immune-Activation. Ceccarelli G, Pinacchio C, Santinelli L, Adami PE, Borrazzo C, Cavallari EN,Vullo A, Innocenti GP, Mezzaroma I, Mastroianni CM, d'Ettorre G.
AIDS Behav. 2020 Apr;24(4):1042-1050. doi:
10.1007/s10461-019-02510-y. PMID: 31016505.
Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically
suppressed HIV-1-infected patients. Santinelli L, Statzu M, Pierangeli A, Frasca F, Bressan A, Pinacchio C, Nonne C, Turriziani O, Antonelli G, d'Ettorre G, Scagnolari C.
Cytokine. 2019 Aug;120:273-281. doi:10.1016/j.cyto.2019.01.012. Epub 2019 Mar 23. PMID: 30910260.
Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-
term-treated HIV-1-infected women. d'Ettorre G, Borrazzo C, Pinacchio C, Santinelli L, Cavallari EN, Statzu M, Fanello G, Ceccarelli G, Antonelli G, Vullo V, Mastroianni CM, Scagnolari C.AIDS. 2019 Mar 15;33(4):627-636. doi: 0.1097/QAD.0000000000002122. PMID: 30608274.
Increased SAMHD1 transcript expression correlates with interferon-related
genes in HIV-1-infected patients. Statzu M, Santinelli L, Viscido A, Pinacchio C, Ceccarelli G, Rotondo C, Corano Scheri G, Mezzaroma I, Turriziani O, Antonelli G, d'Ettorre G, Scagnolari C. Med Microbiol Immunol. 2019
Oct;208(5):679-691. doi: 10.1007/s00430-018-0574-x. Epub 2018 Dec 18. PMID:
30564919.
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters. Immunobiology. Iannetta M, Savinelli S, Rossi R, Mascia C, Marocco R, Vita S, Zuccalà P,
Zingaropoli MA, Mengoni F, Massetti AP, Falciano M, d'Ettorre G, Ciardi MR,
Mastroianni CM, Vullo V, Lichtner M. Immunobiology
2019 Mar;224(2):231-241. doi:10.1016/j.imbio.2018.11.011. Epub 2018 Nov 28. PMID: 30522891.
Cerebrospinal fluid HIV-1 escape according to different thresholds and
underlying comorbidities: is it time to assess the definitions? Trunfio M, Pinnetti C, Focà E, Bai F, Maffongelli G, Celani L, Cinque P,
Celotti A, Andreoni M, D'Arminio Monforte A, D'Ettorre G, Antinori A, Calcagno A.
AIDS. 2019 Mar 15;33(4):759-762. doi: 10.1097/QAD.0000000000002091. PMID: 30531317.
Copy-Years Viremia and Risk of Virological Failure in Long-Term-Treated HIV Patients. Falasca F, De Vito C, Mazzuti L, di Carlo D, Celani L, Fimiani C, dʼEttorre
G, Mezzaroma I, Antonelli G, Turriziani O.
J Acquir Immune Defic
Syndr. 2019 Apr 1;80(4):423-428. doi: 10.1097/QAI.0000000000001931. PMID:
30531307.
A comparison between two dolutegravir-based two-drug regimens
as switch strategies in a multicentre cohort of HIV-1-infected patients. Ciccullo A, Baldin G, Capetti A, Rusconi S, Sterrantino G, d'Ettorre G, Colafigli M, Modica S, Lagi F, Giacomelli A, Cossu MV, Restelli S, De Luca A, Di Giambenedetto S.
Antivir Ther. 2019;24(1):63-67. doi: 10.3851/IMP3270. PMID: 30277466.
Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in
Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic
Supplementation. Pinacchio C, Scheri GC, Statzu M, Santinelli L, Ceccarelli G, Innocenti GP,
Vullo V, Antonelli G, Brenchley JM, d'Ettorre G, Scagnolari C.
J Immunol Res. 2018 Aug 12;2018:1738676. doi: 10.1155/2018/1738676. PMID: 30186879; PMCID: PMC6109550.
HIV-2 Infection in a Migrant from Gambia: The History of the Disease Combined with Phylogenetic Analysis Revealed the Real Source of Infection. Cella E, Foley BT, Riva E, Scolamacchia V, Ceccarelli G, Vita S, Iannetta M, Ciardi MR, D'Ettorre G, Angeletti S, Ciccozzi M. AIDS Res Hum Retroviruses. 2018
Dec;34(12):1090-1094. doi: 10.1089/AID.2018.0112. Epub 2018 Aug 15. PMID:
29954191.
Systemic adipokines,hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs). Pavone P, Alfieri G, Corano-Scheri G, Pinacchio C, Fard SN, Mascia C, Tieghi
T, Lichtner M, d'Ettorre G, Vullo V, Mastroianni CM.
Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):e45-e48. doi: 10.1016/j.clinre.2018.02.004. Epub 2018 May 4. PMID: 29735250.
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically
suppressed HIV-infected patients: 96 week outcomes of a randomized trial.Fabbiani M, Gagliardini R, Ciccarelli N, Quiros Roldan E, Latini A, d'Ettorre G, Antinori A, Castagna A, Orofino G, Francisci D, Chinello P, Madeddu G, Grima P, Rusconi S, Del Pin B, Lombardi F, D'Avino A, Focà E, Colafigli M, Cauda R, Di Giambenedetto S, De Luca A; ATLAS-M Study Group.J Antimicrob Chemother. 2018 Jul 1;73(7):1955-1964. doi: 10.1093/jac/dky123. PMID:
29668978.
Evaluation of coronary features of HIV patients presenting with ACS: The CUORE, a multicenter study. Atherosclerosis. Peyracchia M, De Lio G, Montrucchio C, Omedè P, d'Ettore G, Calcagno A, Vullo V, Cerrato E, Pennacchi M, Sardella G, Manga P, GrossoMarra W, Vullo F, Fedele F, Biondi-Zoccai G, Moretti C, Vachiat A, Bonora S, Rinaldi M, Mancone M, D'Ascenzo F. 2018 Jul;274:218-226. doi: 10.1016/j.atherosclerosis.2018.05.001. Epub 2018 May 5. PMID: 29803160.
Clearance of human papillomavirus related anal condylomas
after oral and endorectal multistrain probiotic supplementation in an HIV
positive male: A case report.Ceccarelli G, Cavallari EN, Savinelli S, Bianchi L, Pierangeli A, Vullo F, Ciardi A, D'ettorre G. Medicine (Baltimore). 2018 Apr;97(16):e0329. doi:
10.1097/MD.0000000000010329. PMID: 29668581; PMCID: PMC5916677.
Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients. Najafi Fard S, Schietroma I, Corano Scheri G, Giustini N, Serafino S, Cavallari EN, Pinacchio C, De Girolamo G, Ceccarelli G, Scagnolari C, Vullo V, d'Ettorre G.
Clin Res Hepatol Gastroenterol.
2018 Sep;42(4):319-329. doi: 10.1016/j.clinre.2017.11.006. Epub 2017 Dec 24.
PMID: 29279268.
Interferon lambda 4 polymorphism is not associated with human papillomavirus infection outcome. Cannella F, Scagnolari C, Statzu M, Sciandra I, Recine N, d'Ettorre G, Antonelli G, Pierangeli A.
Virus Genes. 2018
Apr;54(2):319-322. doi: 10.1007/s11262-017-1527-y. Epub 2017 Dec 14. PMID:
29243064.
Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive
Performance and Central Nervous System Immune Activation of HIV-1 Infected
Individuals.Ceccarelli G, Brenchley JM, Cavallari EN, Scheri GC, Fratino M, Pinacchio C, Schietroma I, Fard SN, Scagnolari C, Mezzaroma I, Vullo V, d'Ettorre G.
Nutrients. 2017 Nov 21;9(11):1269. doi: 10.3390/nu9111269. PMID:
29160817; PMCID: PMC5707741
Long-Term Treatment With Raltegravir is Associated with Lower Triglycerides and Platelets Count in the Older HIV+ Population: Results from the Ral-Age Study. Pavone P, Giustini N, Fimiani C, Paoletti F, Falciano M, Salotti A, Di Sora F, Al Moghazi S, Mezzaroma I, Vullo V, d'Ettorre G. Curr HIV Res. 2017 Nov
23;15(5):355-360. doi: 10.2174/1570162X15666170927124558. PMID: 28969567.
Single-strain versus multistrain probiotic supplementation treatment strategy for rheumatoid arthritis: comment on the article by Marietta et al. Ceccarelli G, Vullo V, d'Ettorre G.
Arthritis Rheumatol. 2018 Feb;70(2):320-321.
doi: 10.1002/art.40332. Epub 2017 Dec 15. PMID: 28950438.
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns.Falasca F, Di Carlo D, De Vito C, Bon I, d'Ettorre G, Fantauzzi A, Mezzaroma I, Fimiani C, Re MC, Vullo V, Antonelli G, Turriziani O.
BMC Infect Dis. 2017 Aug 22;17(1):581. doi: 10.1186/s12879-017-2676-2.
PMID: 28830393; PMCID: PMC5568129.
A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients. Ceccarelli G, Fratino M, Selvaggi C, Giustini N, Serafino S, Schietroma I, Corano Scheri G, Pavone P, Passavanti G, Alunni Fegatelli D, Mezzaroma I, Antonelli G, Vullo V, Scagnolari C, d'Ettorre G.
Brain Behav. 2017 Jul 16;7(8):e00756. doi: 10.1002/brb3.756. PMID: 28828217; PMCID: PMC5561317.
Cardiovascular risk and dyslipidemia among persons living with HIV: a review. Maggi P, Di Biagio A, Rusconi S, Cicalini S, D'Abbraccio M, d'Ettorre G, Martinelli C, Nunnari G, Sighinolfi L, Spagnuolo V, Squillace N. BMC Infect Dis.
2017 Aug 9;17(1):551. doi: 10.1186/s12879-017-2626-z. PMID: 28793863; PMCID:
PMC5550957.
Modulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus-Positive Patients: Preliminary
Results of a New Study Approach.Scheri GC, Fard SN, Schietroma I, Mastrangelo A, Pinacchio C, Giustini N, Serafino S, De Girolamo G, Cavallari EN, Statzu M, Laghi L, Vullo A, Ceccarelli
G, Vullo V, d'Ettorre G. Int J Tryptophan Res. 2017 May
30;10:1178646917710668. doi: 10.1177/1178646917710668. PMID: 28607543; PMCID:PMC5457170.
Probiotic supplementation promotes a reduction in T-cell activation, an
increase in Th17 frequencies, and a recovery of intestinal epithelium integrity
and mitochondrial morphology in ART-treated HIV-1-positive patients. d'Ettorre G, Rossi G, Scagnolari C, Andreotti M, Giustini N, Serafino S, Schietroma I, Scheri GC, Fard SN, Trinchieri V, Mastromarino P, Selvaggi C, Scarpona S, Fanello G, Fiocca F, Ceccarelli G, Antonelli G, Brenchley JM, Vullo V.
Immun Inflamm Dis. 2017 Sep;5(3):244-260. doi: 10.1002/iid3.160. Epub 2017 Apr 20.
PMID: 28474815; PMCID: PMC5569369.
Trans-dissemination of exosomes from HIV-1-infected cells fosters both HIV-1 trans-infection in resting CD4⁺ T lymphocytes and reactivation of the HIV-1 reservoir. Chiozzini C, Arenaccio C, Olivetta E, Anticoli S, Manfredi F, Ferrantelli F,
d'Ettorre G, Schietroma I, Andreotti M, Federico M.
Arch Virol. 2017 Sep;162(9):2565-2577. doi: 10.1007/s00705-017-3391-4. Epub 2017 May
4. PMID: 28474225.
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of
switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing
triple therapy in the randomized AtLaS-M trial. Lombardi F, Belmonti S, Quiros-Roldan E, Latini A, Castagna A, D'Ettorre G, Gagliardini R, Fabbiani M, Cauda R, De Luca A, Di Giambenedetto S; AtLaS-M Study Group.
J Antimicrob Chemother. 2017 Jul
1;72(7):2055-2059. doi: 10.1093/jac/dkx068. PMID: 28333353.
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of
atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected
patients: 48 week results from a randomized trial (ATLAS-M). Di Giambenedetto S, Fabbiani M, Quiros Roldan E, Latini A, D'Ettorre G, Antinori A, Castagna A, Orofino G, Francisci D, Chinello P, Madeddu G, Grima P, Rusconi S, Di Pietro M, Mondi A, Ciccarelli N, Borghetti A, Focà E, Colafigli M, De Luca A, Cauda R; Atlas-M Study Group.
J Antimicrob Chemother. 2017 Apr 1;72(4):1163-1171. doi: 10.1093/jac/dkw557. PMID: 28093483.
Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians.Maggi P, De Socio GV, Cicalini S, D'Abbraccio M, Dettorre G, Di Biagio A, Martinelli C, Nunnari G, Rusconi S, Sighinolfi L, Spagnuolo V, Squillace N. New Microbiol. 2017 Apr;40(2):139-142. Epub 2017 Jan 10. PMID: 28072892.
HCV and diabetes: towards a 'Sustained' glycaemic improvement after treatment with DAAs? Pavone P, Tieghi T, d'Ettorre G, Lichtner M, Marocco R, Mezzaroma I,
Passavanti G, Vittozzi P, Mastroianni C, Vullo V.
- Authors' reply.Clin Microbiol Infect. 2017 May;23(5):344. doi: 10.1016/j.cmi.2016.12.004. Epub 2016 Dec 14. PMID: 27986519.
Trends in drug resistance-associated mutations in a real-life cohort of Italian patients
infected with HIV-1. Montagna C, Mazzuti L, Falasca F, Maida P, Bucci M, D'Ettorre G, Mezzaroma I, Fantauzzi A, Alvaro N, Vullo V, Antonelli G, Turriziani O.
J Glob Antimicrob Resist. 2015 Dec;3(4):267-272. doi:
10.1016/j.jgar.2015.07.006. Epub 2015 Aug 22. PMID: 27842871.
Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse
events associated with dacomitinib in patients with advanced non-small-cell lung
cancer enrolled in ARCHER-1042 trial. Ceccarelli G, Schietroma I, Corano Scheri G, d'Ettorre G, Vullo V.
Ann Oncol. 2016 Nov;27(11):2137-2138. doi:
10.1093/annonc/mdw298. Epub 2016 Aug 8. PMID: 27502719
Probiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study. Scagnolari C, Corano Scheri G, Selvaggi C, Schietroma I, Najafi Fard S,
Mastrangelo A, Giustini N, Serafino S, Pinacchio C, Pavone P, Fanello G,
Ceccarelli G, Vullo V, d'Ettorre G.
Int J Mol Sci. 2016 Sep 27;17(10):1639. doi: 10.3390/ijms17101639. PMID:
27689995; PMCID: PMC5085672.
Prevalence and predictors of long corrected QT interval in HIV-positive
patients: a multicenter study Gili S, Mancone M, Ballocca F, Grosso Marra W, Calcagno A, D'Ettorre G, Cannillo M, D'Ascenzo F, Orofino G, Marruncheddu L, Lonni E, Cinque A, Vullo F,Ceccarelli G, Vilardi I, Sardella G, Vullo V, Moretti C, Fedele F, Bonora S,
Gaita F. J Cardiovasc Med (Hagerstown). 2017
Jul;18(7):539-544. doi: 10.2459/JCM.0000000000000436. PMID: 27635938.
IFN- stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1
infection. Monteleone K, Scheri GC, Statzu M, Selvaggi C, Falasca F, Giustini N,
Mezzaroma I, Turriziani O, d'Ettorre G, Antonelli G, Scagnolari C.
Arch Virol. 2016 Nov;161(11):3263-8. doi: 10.1007/s00705-016-3016-3.
Epub 2016 Aug 24. PMID: 27558125.
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study Latini A, Fabbiani M, Borghi V, Sterrantino G, Giannetti A, Lorenzini P, Loiacono L, Ammassari A, Bellagamba R, Colafigli M, D'Ettorre G, Di Giambenedetto S, Antinori A, Zaccarelli M.
BMC Infect Dis. 2016 Aug
11;16(1):401. doi: 10.1186/s12879-016-1703-z. PMID: 27515949; PMCID: PMC4982404.
Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients.
Viggiani V, Palombi S, Gennarini G, D'Ettorre G, De Vito C, Angeloni A,
Frati L, Anastasi E. Scand J Gastroenterol. 2016 Oct;51(10):1257-62. doi:
10.1080/00365521.2016.1183705. Epub 2016 May 26. PMID: 27227515.
What happens to cardiovascular system behind the undetectable level of HIV viremia? d'Ettorre G, Ceccarelli G, Pavone P, Vittozzi P, De Girolamo G, SchietromaI, Serafino S, Giustini N, Vullo V.
AIDS Res Ther. 2016 Apr 27;13:21. doi:10.1186/s12981-016-0105-z. PMID: 27127532; PMCID: PMC4848790.
IFN-α promotes rapid human Treg contraction and late Th1-like Treg decrease.Pacella I, Timperi E, Accapezzato D, Martire C, Labbadia G, Cavallari EN, D'Ettorre G, Calvo L, Rizzo F, Severa M, Coccia EM, Vullo V, Barnaba V, Piconese S.
J Leukoc Biol. 2016 Sep;100(3):613-23. doi: 10.1189/jlb.5A0415-140R. Epub 2016
Feb 26. PMID: 26921346.
Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. D'Abramo A, Zingaropoli MA, Oliva A, D'Agostino C, Al Moghazi S, De Luca G,
Iannetta M, d'Ettorre G, Ciardi MR, Mastroianni CM, Vullo V.
PLoS One. 2016 Feb 25;11(2):e0149601. doi: 10.1371/journal.pone.0149601. PMID:
26913505; PMCID: PMC4767229.
Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents.
Pavone P, Tieghi T, d'Ettorre G, Lichtner M, Marocco R, Mezzaroma I,
Passavanti G, Vittozzi P, Mastroianni CM, Vullo V.
Clin Microbiol Infect. 2016 May;22(5):462.e1-3. doi: 10.1016/j.cmi.2015.12.030.
Epub 2016 Jan 23. PMID: 26812446.
Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T
cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected
patients on antiretroviral therapy. d'Ettorre G, Ceccarelli G, Serafino S, Giustini N, Cavallari EN, Bianchi L, Pavone P, Bellelli V, Turriziani O, Antonelli G, Stroffolini T, Vullo V.
J Med Virol. 2016 Aug;88(8):1347-56. doi: 10.1002/jmv.24475. Epub 2016 Jan 20. PMID: 26765625.
Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis.
Michelini Z, Baroncelli S, Fantauzzi A, Pasquale C, Galluzzo CM, Sanchez M, Gatto M, Amici R, Franco M, d'Ettorre G, Fimiani C, Mezzaroma I, Vullo V, Merli M, Palmisano L. HIV Clin Trials. 2016 Mar;17(2):49-54. doi: 10.1080/15284336.2015.1125077. Epub 2016 Jan 7. PMID: 26739837.
ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response.
Scagnolari C, Monteleone K, Selvaggi C, Pierangeli A, D'Ettorre G, Mezzaroma I, Turriziani O, Gentile M, Vullo V, Antonelli G.
Immunobiology. 2016 Feb;221(2):282-90. doi: 10.1016/j.imbio.2015.10.007. Epub
2015 Oct 30. PMID: 26563749.
An epidemiological investigation to reconstruct a probable human immunodeficiency virus-1 transmission network: a case report. Serafino S, Cella E, Montagna C, Cavallari EN, Vittozzi P, Lo Presti A, Giovanetti M, Mazzuti L, Turriziani O, Ceccarelli G, d'Ettorre G, Vullo V, Ciccozzi M.
J Med Case Rep.2015 Nov 3;9:253. doi: 10.1186/s13256-015-0717-2. PMID: 26527158; PMCID:PMC4630910.
State of the Art of Dual Therapy in 2015.Nozza S, Svicher V, Saracino A, d'Ettorre G, De Luca A, Maggiolo F, Bonora S, di Biagio A, Rusconi S, Mussini C.
AIDS Rev. 2015 Jul-Sep;17(3):127-34. PMID: 26450801.
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive
multidrug resistant Acinetobacter baumannii causing severe infections in a
Paediatric Intensive Care Unit. Ceccarelli G, Oliva A, d'Ettorre G, D'Abramo A, Caresta E, Barbara CS, Mascellino MT, Papoff P, Moretti C, Vullo V, Visca P, Venditti M.
BMC Infect Dis. 2015 Sep 30;15:393. doi:
10.1186/s12879-015-1133-3. PMID: 26424078; PMCID: PMC4589198.

Reduced risk of Efavirenz Discontinuation in Naïve Patients
Starting First-Line Antiretroviral Therapy with Single Tablet versus dual Tablet
Regimen.
Fabbiani M, Zaccarelli M, Latini A, Sterrantino G, D'Ettorre G, Grima P,
Mondi A, Rossetti B, Borchi B, Giuliani M, Antinori A, De Luca A, Di
Giambenedetto S.
HIV Med. 2016 May;17(5):385-9. doi: 10.1111/hiv.12313. Epub 2015 Sep
22. PMID: 26394902.
Apoptotic Epitope-Specific CD8+ T Cells and Interferon Signaling Intersect in Chronic
Hepatitis C Virus Infection. Martini H, Citro A, Martire C, D'Ettorre G, Labbadia G, Accapezzato D, Piconese S, De Marzio P, Cavallari EN, Calvo L, Rizzo F, Severa M, Coccia EM, Grazi GL, Di Filippo S, Sidney J, Vullo V, Sette A, Barnaba V.
J Infect Dis. 2016 Feb 15;213(4):674-83. doi:
10.1093/infdis/jiv460. Epub 2015 Sep 19. PMID: 26386427.
Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the "Probio-HIV" Clinical Trial. d'Ettorre G, Ceccarelli G, Giustini N, Serafino S, Calantone N, De Girolamo G, Bianchi L, Bellelli V, Ascoli-Bartoli T, Marcellini S, Turriziani O,
Brenchley JM, Vullo V.
PLoS One.
2015 Sep 16;10(9):e0137200. doi: 10.1371/journal.pone.0137200. PMID: 26376436;
PMCID: PMC4573418.
Analysis of Th17 and Tc17 Frequencies and Antiviral Defenses in Gut-Associated Lymphoid Tissue of Chronic HIV-1 Positive Patients. d'Ettorre G, Ceccarelli G, Andreotti M, Selvaggi C, Giustini N, Serafino S, Schietroma I, Nunnari G, Antonelli G, Vullo V, Scagnolari C.
Mediators Inflamm. 2015;2015:395484. doi: 10.1155/2015/395484. Epub 2015 Jun 28. PMID: 26221062; PMCID: PMC4499407.
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro. Matteucci C, Minutolo A, Pollicita M, Balestrieri E, Grelli S, D'Ettorre G, Vullo V, Bucci I, Luchini A, Aquaro S, Sinibaldi-Vallebona P, Macchi B, Perno CF, Mastino A, Garaci E.
Expert Opin Biol Ther. 2015;15 Suppl 1:S83-100. doi:
10.1517/14712598.2015.1021677. Epub 2015 Jun 22. PMID: 26094546.
Impact of switching from lopinavir/ritonavir to boosted and un-boosted atazanavir on glucose metabolism: the ATAzanavir & GLUcose metabolism (ATAGLU) study. d'Ettorre G, Ceccarelli G, Zaccarelli M, Ascoli-Bartoli T, Bianchi L, Bellelli V, De Girolamo G, Serafino S, Giustini N, Mastroianni CM, Vullo V.
Int J STD AIDS. 2016 Jul;27(8):638-43. doi: 10.1177/0956462415590724.
Epub 2015 Jun 10. PMID: 26068963.
HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective. Sarmati L, D'Ettorre G, Parisi SG, Andreoni M.
Curr HIV Res. 2015;13(3):250-7. doi: 10.2174/1570162x13666150407142539. PMID:
25845389; PMCID: PMC4460281.
MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients. Monteleone K, Selvaggi C, Cacciotti G, Falasca F, Mezzaroma I, D'Ettorre G, Turriziani O, Vullo V, Antonelli G, Scagnolari C. BMC Infect Dis. 2015 Feb 12;15:51. doi:
10.1186/s12879-015-0768-4. PMID: 25808800; PMCID: PMC4336718.
Dynamics of HIV DNA and residual viremia in patients treated with a raltegravir-containing regimen. Falasca F, Mazzuti L, DʼEttorre G, Paoletti F, Tripolino O, Serafino S, Antonelli G, Turriziani O. J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):e18-20. doi: 10.1097/QAI.0000000000000414. PMID: 25590274.
Mobile phone microbial contamination among neonatal unit healthcare workers. Orsi GB, Natale F, d'Ettorre G, Protano C, Vullo V, De Curtis M.
Infect Control Hosp Epidemiol. 2015 Apr;36(4):487-9. doi: 10.1017/ice.2015.2. PMID:
25782910.
Normocaloric low cholesterol diet modulates Th17/Treg balance in patients with chronic hepatitis C virus infection.
Gori M, Vullo V, Balsano C. Maggio R, Viscomi C, Andreozzi P, D'Ettorre G, Viscogliosi G, Barbaro B,
PLoS One. 2014 Dec 22;9(12):e112346. doi: 10.1371/journal.pone.0112346. PMID:
25532016; PMCID: PMC4273946.
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis. Zaccarelli M, Fabbiani M, Pinnetti C, Borghi V, Giannetti A, Sterrantino G, Lorenzini P, Latini A, Loiacono L, Colafigli M, Ammassari A, D'Ettorre G, Plazzi M, Di Giambenedetto S, Antinori A.
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19802. doi: 10.7448/IAS.17.4.19802. PMID: 25397546; PMCID: PMC4225349.
Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.
d'Ettorre G, Baroncelli S, Micci L, Ceccarelli G, Andreotti M, Sharma P,
Fanello G, Fiocca F, Cavallari EN, Giustini N, Mallano A, Galluzzo CM, Vella S,
Mastroianni CM, Silvestri G, Paiardini M, Vullo V.
PLoS One. 2014 Oct 23;9(10):e109791. doi: 10.1371/journal.pone.0109791. PMID:
25340778; PMCID: PMC4207675.
Rate and determinants of residual viremia in multidrug- experienced patients successfully treated with raltegravir-based regimens. Baroncelli S, Pirillo MF, Galluzzo CM, Antoni AD, Ladisa N, Francisci D, d'Ettorre G, Segala D, Vivarelli A, Sozio F, Cirioni O, Weimer LE, Fragola V,
Parruti G, Floridia M.
AIDS Res Hum Retroviruses. 2015 Jan;31(1):71-7. doi: 10.1089/AID.2014.0060. PMID:
25092266; PMCID: PMC4287117.
Taming HIV-related inflammation with physical activity: a matter of timing. d'Ettorre G, Ceccarelli G, Giustini N, Mastroianni CM, Silvestri G, Vullo V.
AIDS Res Hum Retroviruses. 2014 Oct;30(10):936-44. doi: 10.1089/AID.2014.0069.
Epub 2014 Sep 17. PMID: 25055246; PMCID: PMC4179917.
Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study. Sargentini V, Ceccarelli G, D'Alessandro M, Collepardo D, Morelli A, D'Egidio A, Mariotti S, Nicoletti AM, Evangelista B, D'Ettorre G, Angeloni A, Venditti M, Bachetoni A. Clin Chem Lab Med. 2015Mar;53(4):567-73. doi: 10.1515/cclm-2014-0119. PMID: 24897401.
Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical
significance in chronically HIV-1-infected patients. Monteleone K, Di Maio P, Cacciotti G, Falasca F, Fraulo M, Falciano M, Mezzaroma I, D'Ettorre G, Turriziani O, Scagnolari C.
Med Microbiol Immunol. 2014 Jun;203(3):207-16. doi: 10.1007/s00430-014-0329-2. Epub 2014 Feb 20. PMID: 24553842.
Guillain Barre syndrome in an HIV-1-infected patient after the beginning of
combined antiretroviral therapy: an immune reconstitution inflammatory syndrome?
Fantauzzi A, Digiulio MA, Cavallari EN, d'Ettorre G, Vullo V, Mezzaroma I.
New Microbiol. 2014 Jan;37(1):103-7. Epub 2014 Jan 15. PMID: 24531178.
Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of
Osteoprotegerin. D'Abramo A, D'Agostino C, Oliva A, Iannetta M, D'Ettorre G, Vullo F,
Mancone M, Ciardi MR, Mastroianni CM, Vullo V.
ISRN AIDS. 2013 Dec 5;2013:737083. doi: 10.1155/2013/737083.
PMID: 24383040; PMCID: PMC3870131.
Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial. Rusconi S, Vitiello P, Adorni F, Colella E, Focà E, Capetti A, Meraviglia P, Abeli C, Bonora S, D'Annunzio M, Di Biagio A, Di Pietro M, Butini L, Orofino G, Colafigli M, d'Ettorre G, Francisci D, Parruti G, Soria A, Buonomini AR,
Tommasi C, Mosti S, Bai F, Di Nardo Stuppino S, Morosi M, Montano M, Tau P,
Merlini E, Marchetti G.
PLoS One. 2013 Nov 14;8(11):e80157. doi: 10.1371/journal.pone.0080157.
PMID: 24244635; PMCID: PMC3828227.
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study).Fabbiani M, Mondi A, Colafigli M, D'Ettorre G, Paoletti F, D'Avino A, Ciccarelli N, Sidella L, Murri R, Fortuna S, Vullo V, Cauda R, De Luca A, Di Giambenedetto S.
Scand J Infect Dis. 2014
Jan;46(1):34-45. doi: 10.3109/00365548.2013.840920. Epub 2013 Oct 28. PMID:
24161018.
Kidney disease in HIV-infected patients. Scarpino M, Pinzone MR, Di Rosa M, Madeddu G, Focà E, Martellotta F, Schioppa O, Ceccarelli G, Celesia BM, d'Ettorre G, Vullo V, Berretta S,
Cacopardo B, Nunnari G. Eur Rev Med
Pharmacol Sci. 2013 Oct;17(19):2660-7. PMID: 24142615.
Recovery of interleukin-17 production from interleukin-15-stimulated CD4+ mononuclear cells in HIV-1-infected patients with sustained viral suppression. Zaffiri L, d'Ettorre G, Ceccarelli G, Andreotti M, Marcellini S, Giustini N, Ascoli-Bartoli T, Mastroianni CM, Vella S, Vullo V. J Interferon Cytokine Res. 2014 Jan;34(1):35-40. doi: 10.1089/jir.2012.0011. Epub 2013 Oct 8. PMID: 24102576.
Buschke-Löwenstein tumor with squamous cell carcinoma treated with chemo-radiation therapy and local surgical excision: report of three cases. Indinnimeo M, Impagnatiello A, D'Ettorre G, Bernardi G, Moschella CM, Gozzo
P, Ciardi A, Bangrazi C, De Felice F, Musio D, Tombolini V.
World J Surg Oncol. 2013 Sep16;11:231. doi: 10.1186/1477-7819-11-231. PMID: 24040860; PMCID: PMC3848791.
Effects of raltegravir on 2-long terminal repeat circle junctions in HIV type 1 viremic
and aviremic patients. Bona R, Baroncelli S, D'Ettorre G, Andreotti M, Ceccarelli G, Filati P,
Leone P, Blasi M, Michelini Z, Galluzzo CM, Mallano A, Vullo V, Cara A.
AIDS Res Hum Retroviruses. 2013 Oct;29(10):1365-9. doi:10.1089/AID.2013.0047. Epub 2013 Jul 24. PMID: 23802629; PMCID: PMC3785805.
HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-
coding control region rearrangements and host immunity.Iannetta M, Bellizzi A, Lo Menzo S, Anzivino E, D'Abramo A, Oliva A, D'Agostino C, d'Ettorre G, Pietropaolo V, Vullo V, Ciardi MR.
J Neurovirol. 2013 Jun;19(3):274-9. doi: 10.1007/s13365-013-0167-9. Epub 2013 May 29. PMID:23715894; PMCID: PMC3695672.
Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic. Pinzone MR, Di Rosa M, Malaguarnera M, Madeddu G, Focà E, Ceccarelli G,
d'Ettorre G, Vullo V, Fisichella R, Cacopardo B, Nunnari G.
Eur Rev Med Pharmacol Sci. 2013 May;17(9):1218-32. PMID: 23690192.
HIV-2 Study Group. An HIV type 2 case series in Italy: a phylogenetic analysis.D'Ettorre G, Lo Presti A, Gori C, Cella E, Bertoli A, Vullo V, Perno CF, Ciotti M, Foley BT, Ciccozzi M;
AIDS Res Hum Retroviruses. 2013 Sep;29(9):1254-9. doi: 10.1089/aid.2013.0091. Epub 2013 May 25. PMID: 23638670.
Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. Matusali G, Tchidjou HK, Pontrelli G, Bernardi S, D'Ettorre G, Vullo V, Buonomini AR, Andreoni M, Santoni A, Cerboni C, Doria M.
FASEB J. 2013 Jun;27(6):2440-50. doi:
10.1096/fj.12-223057. Epub 2013 Feb 8. PMID: 23395909.
Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary? Falcone M, Russo A, Cassetta MI, Lappa A, Tritapepe L, d'Ettorre G, Fallani S, Novelli A, Venditti M.
J Infect Chemother. 2013 Aug;19(4):732-9. doi:10.1007/s10156-013-0559-z. Epub 2013 Jan 30. PMID: 23361566.
The challenge of cardiovascular diseases in HIV-positive patients: it's time for redrawing the maps of cardiovascular risk? Ceccarelli G, d'Ettorre G, Vullo V.
Int J Clin Pract. 2013 Jan;67(1):1-3. doi: 10.1111/ijcp.12066. PMID: 23241044.
Urinary schistosomiasis in asylum seekers in Italy: an emergency currently undervalued. Ceccarelli G, d'Ettorre G, Riccardo F, Ceccarelli C, Chiaretti M, Picciarella A, Pacifici LE, Vullo V.
J Immigr Minor Health. 2013
Aug;15(4):846-50. doi: 10.1007/s10903-012-9744-x. PMID: 23135629.
Microbial translocation and infectious diseases: what is the link? D'Ettorre G, Douek D, Paiardini M, Ceccarelli G, Vullo V.
Int J Microbiol. 2012;2012:356981. doi: 10.1155/2012/356981. Epub 2012 Oct 4. PMID: 23091494;
PMCID: PMC3471423.
Prevalence of prolonged amenorrhea in HIV-infected women: results from the Italian DIDI study. Cicconi P, Ammassari A, Ladisa N, Di Sora F, Bini T, Pierro P, D'Ettorre G,
Cattelan AM, Vichi F, Monforte AD; DIDI Study Group.
J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):e19-21. doi: 10.1097/QAI.0b013e3182683cb5.
PMID: 23007120.
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C
virus or hepatitis B virus coinfection. Weimer LE, Fragola V, Floridia M, Guaraldi G, Ladisa N, Francisci D, Bellagamba R, Degli Antoni A, Parruti G, Giacometti A, Manconi PE, Vivarelli A,
D'Ettorre G, Mura MS, Cicalini S, Preziosi R, Sighinolfi L, Verucchi G, Libertone R, Tavio M, Sarmati L, Bucciardini R; ISS-NIA Study Group.
J Antimicrob Chemother. 2013 Jan;68(1):193-9. doi: 10.1093/jac/dks341. Epub 2012 Sep 14. PMID: 22984206; PMCID: PMC3522446.
Gut microbial translocation in critically ill children and effects of supplementation with pre- and pro biotics. Papoff P, Ceccarelli G, d'Ettorre G, Cerasaro C, Caresta E, Midulla F, Moretti C. Int J Microbiol. 2012;2012:151393.
doi: 10.1155/2012/151393. Epub 2012 Aug 15. PMID: 22934115; PMCID: PMC3426218.
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors. Bucciardini R, D'Ettorre G, Baroncelli S, Ceccarelli G, Parruti G, Weimer LE, Fragola V, Galluzzo CM, Pirillo MF, Lucattini S, Bellagamba R, Francisci D, Ladisa N, Degli Antoni A, Guaraldi G, Manconi PE, Vullo V, Preziosi R, Cirioni O, Verucchi G, Floridia M; ISS-NIA study group.
Int J STD AIDS. 2012 Jul;23(7):459-63. doi:
10.1258/ijsa.2012.011391. PMID: 22843997.
Induced first abortion rates before and after HIV diagnosis: results of an Italian self-
administered questionnaire survey carried out in 585 women living with HIV. Ammassari A, Cicconi P, Ladisa N, Di Sora F, Bini T, Trotta MP, D'Ettorre G, Cattelan AM, Vichi F, d'Arminio Monforte A; DiDi Study Group. HIV Med. 2013 Jan;14(1):31-9. doi: 10.1111/j.1468-1293.2012.01032.x. Epub 2012 Jun
26. PMID: 22731856.
Contrast-enhanced ultrasonographic (CEUS) and elastosonographic features of a case of testicular Leydig tumor. Cantisani V, Olive M, Di Segni M, Di Leo N, Grazdhani H, D'Ettorre G, Ceccarelli G, Fioravanti C, Ricci P. Ultraschall
Med. 2012 Oct;33(5):409-410. English, German. doi: 10.1055/s-0031-1299430.
Erratum in: Ultraschall Med. 2012 Oct;33(5):410. PMID: 22623134.
Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease. Esposito A, Floridia M, d'Ettorre G, Pastori D, Fantauzzi A, Massetti P, Ceccarelli G, Ajassa C, Vullo V, Mezzaroma I.
BMC Infect Dis. 2011 Dec14;11:341. doi: 10.1186/1471-2334-11-341. PMID: 22166160; PMCID: PMC3297656.
The role of IL-15 in challenging Acquired Immunodeficiency Syndrome.d'Ettorre G, Andreotti M, Ceccarelli G, Galluzzo CM, Mallano A, Massetti AP, Tierno F, Stella S, Amici R, Vella S, Mastroianni CM, Vullo V.
Cytokine. 2012 Jan;57(1):54-60. doi: 10.1016/j.cyto.2011.09.026. Epub 2011 Nov 3. PMID:
22055728.
Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy. Ammassari A, Trotta MP, Shalev N, Tettoni MC, Maschi S, Di Sora F, Orofino G, d'Ettorre G, Bai F, Celesia MB, Quiros Roldan E, Maserati R, Sterrantino G, Tommasi C, Boumis E, Iardino MR, Antinori A. J Acquir Immune Defic Syndr.2011 Dec 1;58(4):e113-5. doi: 10.1097/QAI.0b013e3182359d2a. Erratum in: J Acquir
Immune Defic Syndr. 2012 Jan 1;59(1):e8. Tommassi, Chiara [corrected to Tommasi,
Chiara]. PMID: 22033235.
Significant coronary stenosis detected by coronary computed angiography in asymptomatic HIV infected subjects. d'Ettorre G, Francone M, Mancone M, Ceccarelli G, Ascarelli A, Vullo F, Baroncelli S, Galluzzo MC, Catalano C, Strano S, Fedele F, Mastroianni C, Palmisano L, Vullo V. J Infect. 2012 Jan;64(1):82-8. doi: 10.1016/j.jinf.2011.09.007. Epub 2011 Oct 1. PMID: 21983631.
Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection. Lichtner M, Mastroianni CM, Rossi R, Russo G, Belvisi V, Marocco R, Mascia C, Del Borgo C, Mengoni F, Sauzullo I, d'Ettorre G, D'Agostino C, Massetti AP, Vullo V. PLoS One. 2011;6(5):e19872. doi: 10.1371/journal.pone.0019872. Epub 2011 May 19. PMID: 21625541; PMCID:
PMC3098245.
Purulent Meningitis as an Unusual Presentation of Staphylococcus aureus Endocarditis: A Case Report and Literature Review. Ceccarelli G, d'Ettorre G, Vullo V.
Case Rep Med. 2011;2011:735265. doi: 10.1155/2011/735265. Epub 2011 Mar
28. PMID: 21541188; PMCID: PMC3085484.
Adherence and genotypic drug resistance mutations in HIV-1-infected patients failing
current antiretroviral therapy. d'Ettorre G, Forcina G, Ceccarelli G, Andreotti M, Andreoni C, Rizza C, Massetti AP, Sarmati L, Mastroianni CM, Vella S, Andreoni M, Vullo V.
J Chemother. 2011 Feb;23(1):24-7. doi: 10.1179/joc.2011.23.1.24. PMID: 21482490.
HIV persistence in the gut mucosa of HIV-infected subjects undergoing antiretroviral therapy
correlates with immune activation and increased levels of LPS.d'Ettorre G, Paiardini M, Zaffiri L, Andreotti M, Ceccarelli G, Rizza C,
Indinnimeo M, Vella S, Mastroianni CM, Silvestri G, Vullo V.
Curr HIV Res.2011 Apr;9(3):148-53. doi: 10.2174/157016211795945296. PMID: 21457131.
HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects. Parisi SG, Andreoni C, Sarmati L, Boldrin C, Buonomini AR, Andreis S, Scaggiante R, Cruciani M, Bosco O, Manfrin V, d'Ettorre G, Mengoli C, Vullo V, Palù G, Andreoni M.
J Clin Microbiol. 2011 Apr;49(4):1441-5. doi: 10.1128/JCM.02564-10.
Epub 2011 Mar 2. PMID: 21367995; PMCID: PMC3122871.
Development of Buffalo Hump in the course of antiretroviral therapy
including raltegravir and unboosted atazanavir: a case report and review of the
literature. Ceccarelli G, d'Ettorre G, Marchetti F, Rizza C, Mastroianni CM, Carlesimo
B, Vullo V. J Med Case Rep. 2011 Feb 17;5:70. doi: 10.1186/1752-1947-5-70. PMID:
21329500; PMCID: PMC3047431
HIV- associated immune activation: from bench to bedside. d'Ettorre G, Paiardini M, Ceccarelli G, Silvestri G, Vullo V.
AIDS Res Hum Retroviruses.
2011 Apr;27(4):355-64. doi: 10.1089/aid.2010.0342. Epub 2011 Mar 8. PMID:
21309730.
Accelerated coronary atherosclerosis after execution of percutaneous coronary intervention
in patient with HIV/HCV coinfection: case report and review of the literature.
Ceccarelli G, d'Ettorre G, Mancone M, Francone M, Vullo V.
Cardiovasc Revasc Med. 2011 Jul-Aug;12(4):262-5. doi:
10.1016/j.carrev.2010.11.006. Epub 2011 Jan 26. PMID: 21273145.
Diagnosis of anal human papillomavirus infection: polymerase chain reaction or cytology? Indinnimeo M, d'Ettorre G, Fiore A, Ceccarelli G, Ciardi A, Degener AM,
Moschella CM, Izzo L, Izzo S, Antonelli G, D'Angeli I, Vullo V.
Int J Infect Dis. 2011 Apr;15(4):e232-5. doi: 10.1016/j.ijid.2010.11.012. Epub 2011
Jan 15. PMID: 21239202.
Expression of the mRNA levels for MDR1, MRP1, MRP4, and MRP5 in HIV antiretroviral naive patients: follow-up at 48 weeks after the beginning of therapy. Falasca F, Maida P, Montagna C, Antonelli L, d'Ettorre G, Monteleone K,Antonelli G, Turriziani O. J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):e54-6. doi:
10.1097/QAI.0b013e3181fe4c89. PMID: 21233632.
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction. Fabbiani M, Di Giambenedetto S, Ragazzoni E, D'Ettorre G, Parruti G, Prosperi M, Bracciale L, Cauda R, Navarra P, De Luca A.
Pharmacol Res. 2011 Mar;63(3):249-53. doi:0.1016/j.phrs.2010.11.009. Epub 2010 Dec 2. PMID: 21130167.
Seroconversion of HBsAg in HBeAg positive and HBeAg negative patients with chronic HBV treated with entecavir: a case series. d'Ettorre G, Barbarini G, Corti F, Gobber M, Pastecchia C, Ricci GL, Siciliano M, Annicchiarico BE, Vullo V.
Eur Rev Med Pharmacol Sci. 2010 Jun;14(6):551-4. PMID: 20712263.
Surgical debridement with muscle flap transposition and systemic teicoplanin therapy for infected hip arthroplasty.
d'Ettorre G, Marchetti F, Ceccarelli G, Gizzi F, Tierno F, Falcone M,
Venditti M, Carlesimo B, Vullo V.
Hip Int. 2010 Apr-Jun;20(2):255-7. doi: 10.1177/112070001002000218. PMID:
20544660.
Mutational resistance pattern of HIV type 1 in CD14+ monocytes, CD4+ T cells, and plasma
from treated patients. Turriziani O, Boni A, Falasca F, Graziano F, Bucci M, D'Ettorre G,
Fantauzzi A, Paoletti F, Massetti AP, Mezzaroma I, Antonelli G.
AIDS Res Hum Retroviruses. 2010 Jun;26(6):625-34. doi:
10.1089/aid.2009.0183. PMID: 20507206.
The role of HIV-DNA testing in clinical practice. d'Ettorre G, Zaffiri L, Ceccarelli G, Mastroianni CM, Vullo V.
New Microbiol. 2010 Jan;33(1):1-11. PMID:
20402409.
A seven-year prospective study on spondylodiscitis: epidemiological and microbiological features. D'Agostino C, Scorzolini L, Massetti AP, Carnevalini M, d'Ettorre G,
Venditti M, Vullo V, Orsi GB.
Infection. 2010
Apr;38(2):102-7. doi: 10.1007/s15010-009-9340-8. Epub 2010 Feb 27. PMID:
20191397.
The absence of HIV mutations in cerebrospinal fluid and in peripheral blood mononuclear cells during a regimen containing Trizivir plus tenofovir. d'Ettorre G, Ceccarelli G, Turriziani O, Andreotti M, Massetti P, Rizza C, Vella S, Antonelli G, Mastroianni CM, Vullo V.
J Chemother. 2009 Aug;21(4):455-7. doi:
10.1179/joc.2009.21.4.455. PMID: 19622468.
Expression levels of TLRs involved in viral recognition in PBMCs from HIV-1-infected patients failing antiretroviral therapy. Scagnolari C, Selvaggi C, Chiavuzzo L, Carbone T, Zaffiri L, d'Ettorre G, Girardi E, Turriziani O, Vullo V, Antonelli G.
Intervirology. 2009;52(2):107-14. doi:10.1159/000218082. Epub 2009 May 13. PMID: 19439987.
Infectious aortitis and spondylodiscitis in patients with
endovascular stents. d'Ettorre G, Ceccarelli G, Zaffiri L, Falcone M, Mastroianni CM, Venditti M, Vullo V.
Minerva Med. 2009 Apr;100(2):167-70. PMID: 19390503.
DC contact with HIV-1-infected cells leads to high levels of Env-mediated
virion endocytosis coupled with enhanced HIV-1 Ag presentation. Muratori C, Bona R, Ruggiero E, D'Ettorre G, Vullo V, Andreotti M, Federico M. Eur J Immunol.
2009 Feb;39(2):404-16. doi: 10.1002/eji.200838751. PMID: 19180463.
Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently
undetectable plasma HIV-RNA: a cross-sectional evaluation. Bonora S, Nicastri E, Calcagno A, Gonzalez de Requena D, D'Ettorre G, Sarmati L, Palmisano L, Vullo V, Di Perri G, Andreoni M.
J Med Virol. 2009 Mar;81(3):400-5. doi: 10.1002/jmv.21405. PMID: 19152404
Prognostic factors of long-term CD4+count-guided interruption of antiretroviral
treatment. Sarmati L, Andreoni C, Nicastri E, Tommasi C, Buonomini A, D'Ettorre G,
Corpolongo A, Dori L, Montano M, Volpi A, Narciso P, Vullo V, Andreoni M.
J Med Virol. 2009 Mar;81(3):481-7. doi: 10.1002/jmv.21424. PMID:
19152399.
Hospital- acquired infection surveillance in a neonatal intensive care unit. Orsi GB, d'Ettorre G, Panero A, Chiarini F, Vullo V, Venditti M.
Am J InfectControl. 2009 Apr;37(3):201-3. doi: 10.1016/j.ajic.2008.05.009. Epub 2008 Dec 6. PMID: 19059676.
Type-specific human papillomavirus-DNA load in anal infection in HIV-positive men. Pierangeli A, Scagnolari C, Degener AM, Bucci M, Ciardi A, Riva E, Indinnimeo M, Mancini G, D'Ettorre G, Vullo V, Antonelli G.
AIDS. 2008 Oct 1;22(15):1929-35. doi: 10.1097/QAD.0b013e32830fbd7a. PMID: 18784456.
HIV-1 residual viremia and proviral DNA in patients with
suppressed plasma viral load (<400 HIV-RNA cp/ml) during different
antiretroviral regimens. Nicastri E, Palmisano L, Sarmati L, D'Ettorre G, Parisi S, Andreotti M,
Buonomini A, Pirillo FM, Narciso P, Bellagamba R, Vullo V, Montano M, Di Perri
G, Andreoni M.
Curr HIV Res. 2008 May;6(3):261-6. doi:10.2174/157016208784325010. PMID: 18473790.
Urolithiasis under atazanavir boosted and tenofovir therapy: a case report D'Ettorre G, Zaffiri L, Ceccarelli G, Massetti AP, Mastroianni CM, Vullo V.
J Chemother. 2008 Feb;20(1):143-4. doi: 10.1179/joc.2008.20.1.143. PMID: 18343760.
Atypical localization of Leishmaniasis in an intestinal polyp. Zaffiri L, d'Ettorre G, Massetti AP, Mascellino MT, Mastroianni CM, Vullo V.
Infection. 2008 Mar;36(2):187-8. doi: 10.1007/s15010-007-7038-3. Epub 2008 Mar 10. PMID: 18327682.
Cross-presentation of caspase-cleaved apoptotic self
antigens in HIV infection. Rawson PM, Molette C, Videtta M, Altieri L, Franceschini D, Donato T,Finocchi L, Propato A, Paroli M, Meloni F, Mastroianni CM, d'Ettorre G, Sidney J, Sette A, Barnaba V. Nat Med. 2007 Dec;13(12):1431-9. doi: 10.1038/nm1679.
Epub 2007 Nov 18. PMID: 18026114.
Simplified maintenance therapy with abacavir/lamivudine/zidovudine plus tenofovir after sustained HIV load suppression: four years of follow-up.d'Ettorre G, Zaffiri L, Ceccarelli G, Andreotti M, Massetti AP, Vella S, Mastroianni CM, Vullo V.
HIV Clin Trials. 2007 May-Jun;8(3):182-8. doi: 10.1310/hct0803-182. PMID: 17621465.
Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease
inhibitor-sparing regimens. Sarmati L, Parisi SG, Nicastri E, d'Ettorre G, Andreoni C, Dori L, Gatti F,Montano M, Buonomini AR, Boldrin C, Palù G, Vullo V, Andreoni M.
J Med Virol. 2007 Jul;79(7):880-6. doi:
10.1002/jmv.20914. PMID: 17516532.
Apoptotic cell signaling in lymphocytes from HIV+ patients during successful therapy. Grelli S, Balestrieri E, Matteucci C, Minutolo A, D'Ettorre G, Lauria F,
Montella F, Vullo V, Vella S, Favalli C, Mastino A, Macchi B.
Ann N YAcad Sci. 2006 Dec;1090:130-7. doi: 10.1196/annals.1378.014. PMID: 17384255.
Genotypic resistance of archived and circulating viral strains in the blood of treated HIV-infected
individuals. Turriziani O, Bucci M, Stano A, Scagnolari C, Bellomi F, Fimiani C,
Mezzaroma I, D'Ettorre G, Brogi A, Vullo V, Antonelli G.
J Acquir Immune Defic Syndr. 2007 Apr 15;44(5):518-24. doi:
10.1097/QAI.0b013e3180315515. PMID: 17224845.
Apoptosis - associated gene expression in HIV-infected patients in response to successful
antiretroviral therapy. Balestrieri E, Grelli S, Matteucci C, Minutolo A, d'Ettorre G, Di Sora F, Montella F, Vullo V, Vella S, Favalli C, Macchi B, Mastino A.
J Med Virol. 2007 Feb;79(2):111-7. doi: 10.1002/jmv.20768. PMID: 17177302.
Evolving simplified treatment strategies for HIV infection: the role of a single-class quadruple- nucleoside/nucleotide regimen of trizivir and tenofovir. Mastroianni CM, d'Ettorre G, Vullo V. Expert Opin Pharmacother. 2006 Nov;7(16):2233-41. doi: 10.1517/14656566.7.16.2233. PMID: 17059380.
Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis d'Ettorre G, Ceccarelli G, Carnevalini M, Forcina G, Zaffiri L, Massetti AP, Mastroianni CM, Vullo V. Acta Trop. 2006 Aug;99(1):83-7. doi: 10.1016/j.actatropica.2006.08.002. Epub 2006 Sep
11. PMID: 16962979.
Abdominal aortic mycotic aneurysm, psoas abscess, and aorto-bisiliac graft infection due to Salmonella typhimurium Carnevalini M, Faccenna F, Gabrielli R, Irace L, Dell'isola S, d'Ettorre G, Vullo V, Mastroianni CM. J Infect Chemother. 2005 Dec;11(6):297-9. doi: 10.1007/s10156-005-0412-0. Erratum in: J Infect Chemother. 2006 Feb;12(1):52. Faccenna, Fabrizio [corrected to Faccenna,Federico]. PMID: 16369737.
Association between cellular human immunodeficiency virus DNA level and
immunological parameters in patients with undetectable plasma viremia level
during highly active antiretroviral therapy. Sarmati L, Parisi SG, Nicastri E, d'Ettorre G, Palmisano L, Andreotti M, Andreoni C, Giuliano M, Gatti F, Boldrin C, Palù G, Vullo V, Vella S, Andreoni M.
J Clin Microbiol. 2005
Dec;43(12):6183-5. doi: 10.1128/JCM.43.12.6183-6185.2005. PMID: 16333125; PMCID:
PMC1317166.
Interleukin-15 enhances the secretion of IFN-gamma and CC chemokines by natural killer cells from HIV viremic and aviremic patients.
d'Ettorre G, Andreotti M, Carnevalini M, Andreoni C, Zaffiri L, Vullo V,
Vella S, Mastroianni CM.
Immunol Lett. 2006 Mar 15;103(2):192-5. doi: 10.1016/j.imlet.2005.10.001. Epub
2005 Oct 25. PMID: 16289324.
Switching from protease inhibitors to a single-class regimen of abacavir/lamivudine/zidovudine plus tenofovir in patients with HIV load suppression.d'Ettorre G, Mastroianni CM, Massetti AP, Lichtner M, D'Agostino C, Vullo V
AIDS. 2005 May 20;19(8):841-2. doi:
10.1097/01.aids.0000168983.28079.87. PMID: 15867503
Extended Spectrum Beta-Lactamase-producing Klebsiella pneumoniae outbreaks during a third generation cephalosporin restriction policy.
Conte MP, Venditti M, Chiarini F, D'Ettorre G, Zamboni I, Scoarughi GL,
Gallinelli C, Orsi GB.
J Chemother. 2005 Feb;17(1):66-73. doi: 10.1179/joc.2005.17.1.66. PMID:
15828446.
Discordant response to HAART: reduction of viremia and replicative capacity
of HIV strains in patients after genotype guided change of therapy. Sarmati L, Montano M, Dori L, Buonomini AR, D'Ettorre G, Vullo V, Andreoni M.
New Microbiol. 2004 Apr;27(2 Suppl 1):95-8. PMID: 15646070.
Non-B HIV type 1 subtypes: replicative capacity and response to antiretroviral therapy Nicastri E, Sarmati L, d'Ettorre G, Parisi SG, Palmisano L, Montano M,
Buonomini AR, Galluzzo C, Vullo V, Concia E, Vella S, Andreoni M.
AIDS Res Hum Retroviruses. 2004 Aug;20(8):816-8. doi: 10.1089/0889222041725271. PMID: 15320985.
Interleukin-15 modulates interferon-gamma and beta-chemokine production in patients with HIV infection: implications for immune-based therapy. Forcina G, D'Ettorre G, Mastroianni CM, Carnevalini M, Scorzolini L,Ceccarelli G, D'Agostino C, Lichtner M, Massetti AP, Vullo V.
Cytokine. 2004 Mar 21;25(6):283-90. doi: 10.1016/j.cyto.2003.12.004. PMID: 15036244.
Teaching tired T cells to fight HIV: time to test IL-15 for immunotherapy? Mastroianni CM, d'Ettorre G, Forcina G, Vullo V.
Trends Immunol. 2004 Mar;25(3):121-5. doi: 10.1016/j.it.2004.01.002. PMID: 15036038.
Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy. Sarmati L, Nicastri E, Montano M, Dori L, Buonomini AR, d'Ettorre G, Gatti F, Parisi SG, Vullo V, Andreoni M.
J Med Virol. 2004 Apr;72(4):511-6. doi: 10.1002/jmv.20030. PMID: 14981751.
Inverse correlation between CD8+ lymphocyte apoptosis and CD4+ cell counts during potent antiretroviral therapy in HIV patients. Grelli S, d'Ettorre G, Lauria F, Montella F, Di Traglia L, Lichtner M, Vullo V, Favalli C, Vella S, Macchi B, Mastino A.
J Antimicrob Chemother. 2004 Mar;53(3):494-500. doi:
10.1093/jac/dkh105. Epub 2004 Feb 12. PMID: 14963063.
Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy. d'Ettorre G, Forcina G, Andreotti M, Sarmati L, Palmisano L, Andreoni M, Vella S, Mastroianni CM, Vullo V.
Clin Exp Immunol.2004 Feb;135(2):280-5. doi: 10.1111/j.1365-2249.2004.02373.x. Erratum in: ClinExp Immunol. 2004 Apr;136(1):189. PMID: 14738457; PMCID: PMC1808945.
Viral growth assay to evaluate the replicative capacity of HIV-1 isolates.
Nicastri E, Sarmati L, Dori L, Montano M, d'Ettorre G, Buonomini AR, Parisi
SG, Concia E, Vullo V, Andreoni M.
J Virol Methods. 2004Feb;115(2):199-205. doi: 10.1016/j.jviromet.2003.09.032. PMID: 14667536.
CD4+ lymphocyte increases in HIV patients during potent antiretroviral therapy are dependent on inhibition of CD8+ cell apoptosis. Grelli S, D'Ettore G, Lauria F, Montella F, Di Traglia L, D'Agostini C, Lichtner M, Vullo V, Favalli C, Vella S, Macchi B, Mastino A. Ann N Y Acad Sci. 2003 Dec;1010:560-4. doi: 10.1196/annals.1299.104. PMID: 15033791.
High prevalence of M184 mutation among patients with viroimmunologic discordant
responses to highly active antiretroviral therapy and outcomes after change of
therapy guided by genotypic analysis.
Nicastri E, Sarmati L, d'Ettorre G, Parisi SG, Palmisano L, Galluzzo C,
Montano M, Uccella I, Amici R, Gatti F, Vullo V, Concia E, Vella S, Andreoni M.
J Clin Microbiol. 2003 Jul;41(7):3007-12.doi: 10.1128/jcm.41.7.3007-3012.2003. PMID: 12843034; PMCID: PMC165358.
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active
antiretroviral therapy is failing. Sarmati L, Nicastri E, Uccella I, D'Ettorre G, Parisi SG, Palmisano L, Galluzzo C, Concia E, Vullo V, Vella S, Andreoni M.
J Clin Microbiol. 2003 Apr;41(4):1760-2. doi:10.1128/jcm.41.4.1760-1762.2003. PMID: 12682180; PMCID: PMC153869.
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy. Nicastri E, Sarmati L, d'Ettorre G, Palmisano L, Parisi SG, Uccella I, Rianda A, Concia E, Vullo V, Vella S, Andreoni M.
J Med Virol. 2003 Jan;69(1):1-6. doi:
10.1002/jmv.10269. PMID: 12436471.
Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production. D'Ettorre G, Forcina G, Andreotti M, Sarmati L, Palmisano L, Galluzzo CM, Nicastri E, Mastroianni CM, Vullo V, Vella S, Andreoni M.
AIDS. 2002 Sep 27;16(14):1877-85. doi:
10.1097/00002030-200209270-00004. PMID: 12351947.
Matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 in plasma of patients co-infected with HCV and HIV.
Mastroianni CM, Liuzzi GM, D'Ettorre G, Lichtner M, Forcina G, Di Campli
NF, Riccio P, Vullo V.
HIV Clin Trials. 2002 Jul-Aug;3(4):310-5. doi: 10.1310/U9LJ-MFF9-ARE1-257H.
PMID: 12187505.
Discordance between genotypic and phenotypic drug resistance
profiles in human immunodeficiency virus type 1 strains isolated from peripheral
blood mononuclear cells
Sarmati L, Nicastri E, Parisi SG, d'Ettorre G, Mancino G, Narciso P, Vullo V, Andreoni M.
J Clin Microbiol. 2002 Feb;40(2):335-40. doi:
10.1128/jcm.40.2.335-340.2002. PMID: 11825939; PMCID: PMC153419.
Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients. d'Ettorre G, Forcina G, Lichtner M, Mengoni F, D'Agostino C, Massetti AP,Mastroianni CM, Vullo V. AIDS.
2002 Jan 25;16(2):181-8. doi: 10.1097/00002030-200201250-00006. PMID: 11807301
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations. Sarmati L, Nicastri E, Parisi SG, D'Ettorre G, Narciso P, Mancino G, Gallo I, Abbadessa V, Dalle NE, Traina C, Vullo V, Andreoni M.
J Med Virol. 2001 Dec;65(4):631-6. doi: 10.1002/jmv.2083. PMID: 11745924.
Circulating levels of interleukin-7 in antiretroviral-naïve and
highly active antiretroviral therapy-treated HIV-infected patients. Mastroianni CM, Forcina G, d'Ettorre G, Lichtner M, Mengoni F, D'Agostino C, Vullo V.
HIV Clin Trials. 2001 Mar-Apr;2(2):108-12. doi: 10.1310/6V29-4UU5-Y3FP-JERT. PMID: 11590518.
Neutralizing antibodies against autologous humanimmunodeficiency virus Type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment.
Sarmati L, d'Ettorre G, Nicastri E, Ercoli L, Uccella I, Massetti P, Parisi
SG, Vullo V, Andreoni M.
Clin Diagn Lab Immunol. 2001 Jul;8(4):822-4. doi: 10.1128/CDLI.8.4.822-824.2001.
PMID: 11427434; PMCID: PMC96150.
Human immunodeficiency virus-1 specific and natural cellular
immunity in HIV seronegative subjects with multiple sexual exposures to virus.
Nicastri E, Ercoli L, Sarmati L, d'Ettorre G, Iudicone P, Massetti P, Vullo
V, Andreoni M.
J Med Virol. 2001 Jul;64(3):232-7. doi: 10.1002/jmv.1041. PMID: 11424109.
Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-
infected patient with protease inhibitor-related hyperlipidemia.
Mastroianni CM, d'Ettorre G, Forcina G, Lichtner M, Corpolongo A, Coletta
S, Vullo V.
AIDS. 2001 Apr 13;15(6):820-1. doi: 10.1097/00002030-200104130-00029. PMID: 11371708.
Overexpression of lymphocytic GD3 ganglioside and presence of anti-GD3 antibodies in patients with HIV infection.
Misasi R, Sorice M, Garofalo T, Griggi T, Giammarioli AM, D'Ettorre G, Vullo V, Pontieri GM, Malorni W, Pavan A.
AIDS Res Hum Retroviruses. 2000 Oct 10;16(15):1539-49. doi: 10.1089/088922200750006065. PMID: 11054267.
Ex vivo and in vitro effect of human immunodeficiency virus protease inhibitors on neutrophil apoptosis. Mastroianni CM, Mengoni F, Lichtner M, D'Agostino C, d'Ettorre G, Forcina
G, Marzi M, Russo G, Massetti AP, Vullo V.
J Infect Dis. 2000 Nov;182(5):1536-9. doi: 10.1086/315858. Epub 2000 Oct 9. PMID:
11023478.
Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection.
Mastroianni CM, d'Ettorre G, Forcina G, Lichtner M, Mengoni F, D'Agostino
C, Corpolongo A, Massetti AP, Vullo V. Blood. 2000 Sep 1;96(5):1979-84. PMID: 10961903.
Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients.
Mastroianni CM, Lichtner M, Mengoni F, D'Agostino C, d'Ettorre G, Forcina
G, Santopadre P, Massetti AP, Vullo V.
Clin Immunol. 2000 Jun;95(3):212-7. doi:10.1006/clim.2000.4865. PMID: 10866128.
Long-term remission of human immunodeficiency virus-associated visceral leishmaniasis
after initiation of potent combination antiretroviral treatment: report of two
cases. Mastroianni CM, d'Ettorre G, Forcina G, Corpolongo A, Dell'Isola S,
Lichtner M, D'Agostino C, Trinchieri V, Santopadre P, Vullo V.
J Infect. 2000 Jan;40(1):94-6. doi: 10.1053/jinf.1999.0607. PMID: 10762121.
Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects. Nicastri E, Sarmati L, Ercoli L, Mancino G, D'Ambrosio E, d'Ettorre G, Mastroianni CM, Vullo V, Andreoni M.
AIDS. 1999 Jul30;13(11):1333-6. doi: 10.1097/00002030-199907300-00009. PMID: 10449285.
Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients.
Mastroianni CM, Lichtner M, Mengoni F, D'Agostino C, Forcina G, d'Ettorre G, Santopadre P, Vullo V.
AIDS. 1999 May 28;13(8):883-90. doi: 10.1097/00002030-199905280-00003. PMID: 10371168.